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Wildlife diseases can have drastic consequences for species at an unprecedented rate. 
Without proper intervention, diseases can threaten population viability and result in 
species extinction. The delicate balance of an ecosystem is associated with the niche of 
an individual species and can quickly become unstable upon the introduction of an 
invasive disease. Managing these diseases is often quite challenging and typically 
requires immediate action to prevent further ecological loss. The psychrophilic fungus, 
Pseudogymnoascus destructans, Pd, has devastated populations of several North 
American bat species. White-nose syndrome (WNS) is a deadly disease that indirectly 
causes hibernating bat mortality by growing on the cutaneous surfaces of the bat and 
causing more frequent arousal periods. In addition to physiological imbalances caused 
by the degradation of wing tissue, the decreased torpor length and associated 
increased metabolic rate will burn precious fat stores, cause rapid dehydration, and lead 
to bat mortality.  Reducing the severity of the Pd infection could result in lower mortality 
rates.  Experiments on captive bats and free-flying wild bats were conducted to alter 
native wing microflora found on Myotis yumanensis, using a prophylactic topical 
probiotic cocktail. The probiotic contains Pseudomonas bacterial species that were 
isolated from wings of healthy British Columbia bats and were found to inhibit Pd. The 
four main objectives of this study were:  (1) to develop a technique of applying the anti-
Pd microbes to Myotis bats roosting in buildings and/or bat boxes; (2) to test whether an 
microbiome enhanced with anti-Pd microbes can be sustained on bat wings; (3) to 
replicate captive trial tests and procedures in a field trial setting; and (4) to quantify the 
ability of the probiotic to inhibit Pd germination/growth on live bat skin. Two captive bat 
trials at the B.C. Wildlife Park and one lab hibernation trial were conducted. I developed 
an effective two-step application process of misting a roosting substrate with water, 
followed by powdered clay containing freeze-dried probiotic cells. Quantitative PCR 
analyses confirmed successful long term adherence of the probiotic cells to bat boxes, 
and successful transfer of these microbes to  bats’ wings. The probiotic was field-trialed 
at summer maternity roosts in the Greater Vancouver area, successfully applying 
probiotic at building and bat box roosts, and through swab sampling of captures of free-
flying bats, determined the probiotic was successfully transferred.  In a laboratory 
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experiment, I placed probiotic bacteria and Pd onto separated bat patagia, with the goal 
of adapting and refining tissue explant chamber technology to keep bat skin cells 
partially alive on which to test the interaction of Pd and probiotic cells. This probiotic tool 
provides one potential prevention measure for reducing the spread, or at minimum the 
severity, of WNS in the Pacific Northwest of North America. 
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Chapter 1: INTRODUCTION 
Chiroptera is the second largest mammalian order with over 1,400 species found 
worldwide excluding the arctic poles (Simmons and Cirranello 2021). One hundred and 
nine of these species are considered vulnerable, eighty-three are currently endangered, 
and twenty-one are critically endangered (BCI 2021). New bat species are continuously 
being discovered and 242 bat species are data deficient with an unknown conservation 
status (BCI 2021). British Columbia is home to 17 of the 19 bat species found in 
Canada (Naughton 2012).  
All bat species in Canada are insectivores that feed on arthropods (Harvey, et al. 
2011; Nagorsen and Brigham 1995). As such, when insects are not present, starting in 
fall, bats must either migrate or hibernate until insect prey are again abundant. Most bat 
species in Canada are hibernating species, with only 3 that are considered migrating 
species: Lasiurus borealis, L. cinereus, and Lasionycteris novtivagans (Harvey, et al. 
2011; Nagorsen and Brigham 1995). Hibernating species generally roost within mines, 
caves, rock crevices, and in some areas some species will hibernate in trees and 
buildings (Naughton 2012). Hibernation is thought to occur shortly after mating swarms 
in September-October or later (i.e. Myotis. lucifugus, Eptesicus fuscus, M. yumanensis, 
M. californicus, Euderma maculatum, M. septentrionalis, M. evotis, Antrozous pallidus, 
M. thysanodes, M. volans, M. ciliolabrum, M. leibii, L. noctivagans, Parastrellus 
hesperus, Corynorhinus townsendii). Bats may undergo torpor to conserve energy and 
reduce water loss when their ambient temperature is less than their thermoneutral zone 
(Herreid and Schmidt-Nielsen 1966). Torpor decreases their body temperature to match 
their ambient temperature and lower their metabolic rate (Geiser 2004). Basic bodily 
functions such as breathing and heart rate are slowed immensely and their immune 
system is suppressed throughout torpor, making them vulnerable to infection (Bouma et 
al., 2010; Geiser 2004; Moore et al., 2011). Durations of torpor are intermittent and 
often delayed by brief arousals that vary among species, in which body temperature and 
metabolic rate reach normothermic levels briefly before bats re-enter torpor. These 
arousals are the main contributor of stored energy usage when in hibernation (Thomas 




been documented in between bouts of torpor (Boyles et al. 2006; Wilcox et al. 2014). 
After emergence from hibernation, which typically occurs between March-May the 
following spring, females will typically return to previously used maternity roosts whether 
it be a bat box, building, or tree roost. Males will instead form smaller colonies or roost 
by themselves (Naughton 2012).  
Temperate bats choose where to roost based on many factors such as 
thermoregulation, reproduction status, risk, coloniality, and roost quality (Boyles 2007; 
kerth et al. 2008; Lausen and Barclay 2006; Racey et al. 1973). Bats often choose roost 
based on their thermoneutral zone, in which they do not have to regulate their body 
temperature to match their roost (Boyles 2007). This will eliminate unneeded energy 
expenditure in colder temperatures and dehydration from warmer areas (Genoud et al. 
1990). Furthermore, bats undergoing gestation or lactation will choose roosts that do 
not require torpor, to avoid negative effects such as parturition and reduced milk supply 
(Racey 1973; Studier and O’Farrell, 1972). Once maternity colonies are formed in the 
summer, individual bats must decide how to balance risks such as parasitism and 
disease risk in larger maternity colonies, with the benefits of coloniality such as social 
thermoregulation, predator avoidance, and maintenance of social relationships 
(Altrignham 2011; Bartonička and Gaisler 2007; Kerth 2008; Reckardt and Kerth 2007; 
Russo et al. 2017; Webber et al. 2018; Willis and Brigham 2007). 
Roost switching is common to balance these factors and is different between 
artificial and natural roosts (Whitaker 1998). Man made structures such as bridges, and 
buildings often mimic natural roosts quite well, and provide better thermal stability, 
warmer microclimates, and greater protection from predators than natural roosts 
(Lausen and Barclay 2006; Rueegger 2016; Russo and Ancillotto 2015). These 
conditions promote reproductive success, better body condition, faster juvenile 
development, and inevitably less roost switching (Allen et al. 2010; Godhino et al. 2015; 
Lausen and Barclay 2006; Webber et al. 2016; Zahn 1999). 
Species such as, but not limited to, C. townsendii, E. fuscus, and more 




the summer season (Nagorsen 1995). In BC, most bats raise a single young each 
summer, although some migratory species can give birth to up to 4 pups. Most species 
give birth in June each year and pups will depend on their mother’s milk for roughly 6 
weeks until they learn to fly and hunt on their own. Many maternity colonies break up in 
late summer, and it is thought that most bats will arrive at hibernation areas by October, 
and bats mate somewhere either en-route to hibernacula, or at the hibernacula. It is 
now known that some species of bats in B.C. will continue to mate during winter and in 
spring (C. Lausen, pers. comm.)   
Because bats consume thousands of insect prey nightly in the summer, they are 
important environmentally and economically;  the value of insectivorous bats in the 
United States is estimated to be roughly 22.9 billion USD a year (range $3.7 - $53 
billion, Boyles et al. 2011). Humans have a significant impact on bat populations world-
wide, through roost disturbance, habitat loss, direct mortality such as for food 
consumption and persecution, and indirect mortality including exposure to chemicals 
like pesticides (Berthinussen et al. 2014). In North America, deforestation, and 
developments such as roads, buildings, and windfarms contribute to habitat 
fragmentation. Such expansions can result in roost destruction, loss of traditional land 
used for migration and insect feeding and forced movements into uninhabited areas. 
Roads are particularly bad because they restrict foraging access for bats and directly 
contribute to fragmentation and in some cases, casualties (Kerth and Melber 2009; 
Lesinski et al. 2011). Bat casualties are often seen from wind turbines, in which 
hundreds of thousands of bat deaths each year from barotrauma (Baerwald et al. 2008; 
Smallwood 2013), due to migratory movements and unnatural attraction towards the 
turbines (Cryan and Barclay 2009). North American bat species face many cumulative 
conservation threats, however the biggest threat in the last decade, which can likely 
lead to the extinction of several bat species, is White-nose syndrome (WNS). 
White-nose syndrome is a fatal bat disease that is a direct result of infection from 
the fungal pathogen Pseudogymnoascus destructans. The fungus was first discovered 




then it has caused an unknown number of bat mortalities, having been estimated at 
more than 6 million bat deaths in 2012 (USFW 2012). Mortality rates as high as 90-
100% have been reported (Drees et al. 2017; Frick et al. 2010; Frick et al. 2015; 
Leopardi et al. 2015). Pd is currently detected in 39 states and seven Canadian 
provinces (USFW 2020) and has not been officially documented in British Columbia yet. 
However, bat hibernacula in British Columbia (and the Pacific Northwest in its entirety) 
are largely unknown and un-surveyed (Weller et al. 2018). Therefore it is reasonable to 
think WNS has already reached British Columbia and we simply have not detected it 
yet, especially considering the cases found in Washington State came from Kentucky 
(Thapa at al. 2021). 
Differential rate of mortality caused by WNS is due to many factors such as 
species, hibernacula microclimates, and individual bat interactions associated with 
cluster size (Lorch et al. 2011; Wilder et al. 2011). Certain species are more affected 
than others, particularly M. lucifugus), Perimyotis subflavus, M. sodalis, and more 
recently, M. septentrionalis (Frick et al. 2015). The origin of Pd is speculated to be from 
Europe (Drees et al. 2017; Leopardi et al. 2015). Eurasian bats have not suffered the 
same population declines or mass mortalities as seen in North American bats. This is 
likely due to WNS being an invasive novel fungus that North American bat species have 
never encountered or adapted to, unlike bats from Eurasia thought to have co-evolved 
with this fungus (Leopardi et al. 2015). Furthermore, there is genomic evidence that 
Eurasian bats may have co-evolved resistance or tolerance to WNS infection in the past 
(Hoyt et al. 2016; Leopardi et al. 2015).   
Bats have suffered high mortality rates because of Pd’s persistence, growth 
conditions, mechanism of infection, and difficulty to remove from hibernacula. Pd is a 
psychrophilic saprotroph that grows optimally between 12.5-15.8oC in high relative 
humidity conditions of 81.5% (Marroquin et al. 2017; Verant et al. 2012). It may persist 
in caves for centuries and may reinfect bats that use the same area for hibernation 
(Reynolds et al. 2015). Bats who survive until emergence will groom off WNS hyphae 




mass and some wing tissue injuries (Fuller et al. 2020; Reichard and Kunz 2009). 
However, survival of bats after hibernation within infected caves has been largely 
dependant on body weight and greater fat reserves (Cheng et al. 2019; Jonasson and 
Willis 2011) with physiological disturbance and starvation being the main mechanism of 
mortality (Storm and Boyles 2011; Cryan et al. 2013; Warneke et al. 2013; Verant et al. 
2014). E. fuscus can have similar hibernation conditions to vulnerable species, however 
it has exhibited resistance presumably due to its skin microbiota (Frank et al. 2014; 
Lemieux-Labonté et al. 2020). Bat species exposed to re-occurring infection from the 
same hibernacula either reach 100% infection or have a lesser mortality rate, possibly 
due to behavioural or skin microbiota adaptions that previous bats did not have (Frick et 
al. 2017; Hoyt et al. 2015; Langwig et al. 2017).  
An augmented skin microbiota that provides resistance to Pd infection has been 
a promising method of controlling WNS spread. Many ex-vivo laboratory trials have 
demonstrated antagonistic interactions from certain bacteria due to the release of 2,4-
Diacetylphloroglucinol antibiotic metabolite (Delany et al. 2000; Bangera and 
Thomashow 1999). Pseudomonas isolates are commonly used in research studies 
because of its natural abundance within environments, its successful history as an anti-
fungal agent in agriculture, and detected presence within some wild bat wing microbiota 
(Cheng et al. 2016; Lemieux-Labonté et al. 2017; Hoyt et al. 2015).  
Several studies have used bacteria from the P. fluorescens species complex for 
anti-Pd experiments, both in the lab and field (Cheng et al. 2016; Lemieux-Labonté et 
al., 2017; Hoyt et al. 2015; Hoyt et al. 2019). Bacteria within the Pseudomonas genus 
are characterized by their rod shape (0.5-1.0 µm diameter, 1.5-5.0 µm in length) and 
gram negative morphology. They are aerobic with an optimum growth temperature 
between 4-42oC and are commonly found within soils (Bossis et al. 2000; Chakravarty 
and Gregory 2015). P. fluorescens is a species complex that was previously noted as 
an individual species but is instead composed of a wide range of ~52 diverse species 
that form their own phylogenetic group and comprise the same core proteome (Garrido-




the advantages of 16s rRNA genotyping in the late 20th century that has resulted in 
many bacteria to be re-classified from the Pseudomonas genus (Anzai et al. 2000). In 
this thesis, we use a probiotic cocktail of synergistic P. fluorescens bacteria species that 
display anti-Pd properties. All four species belong with the P. fluorescens species 
complex, P. azotoformans and P. synxantha strains A and B, and  P. antarctica 
(Nikolaidis et al. 2020). P. azotoformans exhibits antifungal properties and have 
previously been used as a biocontrol agent against cucumber Colletotrichum orbiculare 
(Sang et al. 2014). It was isolated from an adult C. townsendii caught from a maternity 
roost in Deroche, British Columbia. P. synxantha is a bacteria species commonly found 
within the rhizosphere of plants and exhibits nematocidal and antifungal properties 
(Wechter et al. 2002)(Janakiev et al 2019). Strain A was isolated from a M. yumanensis 
at a mine hibernaculum near Salmo, British Columbia. Strain B was isolated from an 
adult female E. fuscus caught from a mine near Salmo, British Columbia. P. antarctica 
was first isolated by Gundlapalli et al. in 2004 in Wright Valley, Antarctica. It is a 
psychrophilic aerobic species that grows optimally between 4-30oC. It is the most exotic 
species in our cocktail and was isolated from a female juvenile M. evotis at a mine 
hibernaculum near Nelway, British Columbia.  
Very few studies have conducted field trials that implement anti-Pd bacteria into 
wild bat populations due to the inherit difficulty of treatment, especially in western bat 
species, and risks of upsetting the natural balance of skin microbiota (Cheng et al. 
2016; Hoyt et al. 2019). Researchers have considered creative solutions such as raising 
bat hibernacula temperatures to reduce torpor and introducing UV lights to prevent Pd 
growth however these are largely dependent on knowledge of hibernacula (Boyles and 
Willis 2010; Palmer et al. 2018;). Studies have also considered and/or tested vaccines, 
antifungal drugs, chitosan, other fungi, propolis, orange oil and other volatile organic 
compounds to fight WNS (Boire et al. 2016; Chaturvedi et al. 2011; Cornelison et al. 
2014a; Cornelison et al. 2014b; Ghosh et al. 2017; Hoyt et al. 2015; Kulhanek 2016; 
Lemieux-Labonté et al., 2017; Micalizzi and Smith 2020; Robbins et al. 2011; Rocke et 




There are currently no methods available to prevent the spread of WNS, 
especially in western bat species. There has been no official documentation of WNS in 
British Columbia (WNS 2019), therefore a proactive approach to preventing infection is 
still possible. Once infected, it would be difficult to treat bats in British Columbia due to 
hibernacula being largely unknown, likely remote, and all known hibernacula contain 
few bats and few species (Fletcher et al. 2020; Weller et al. 2018). Fletcher et al. (2020) 
recommends that treatment measures should be considered that do not require 
knowledge of bat hibernacula in western North America. This study proposes the first 
bioactive treatment of WNS for western bat species. 
This project’s goal was to test a newly developed anti-Pd prophylaxis (Forsythe 
et al. 2021) to prevent western bat mortality due to WNS. The first objective was to test 
the probiotic in a captive setting to confirm that a sustained changed in wing microbiota 
can be achieved. I hypothesized that if I introduce the probiotic bacteria onto bat wings, 
then probiotic bacterial species will be detected on their wings for some period of time 
following application. I wanted to determine how long the probiotic can be detected on 
captive and wild bat wings following inoculation. The second objective is to develop an 
application method that is safe, replicable, easy to do, and inexpensive for widespread 
use in the Pacific Northwest. If a universal application method was developed, then it 
could be transitioned into field testing and widespread use. Since probiotic cells cannot 
be inoculated directly, a carrier agent needs to be utilized, specifically one that does not 
harm bats and replicates a substance found in the wild. The third objective is to 
successfully apply probiotic onto wild bat roosts and monitor levels of detected probiotic 
on their wings. If I were to replicate the methodology from the captive trial into a field 
trial on wild bats, then there should be a detectable concentration of probiotic on their 
wings. This is especially important because widespread use is dependant on successful 
field trial results. Finally, the fourth objective involves describing and quantifying 
probiotic and Pd interactions on live bat skin. If I inoculate Pd onto wing tissue from the 
captive trials, then I should see some antagonistic interactions from the probiotic 




chambers, in which wing tissue is inoculated with Pd and the probiotic bacteria at the 
same time and monitored for abundance using qPCR.  
Here I present, in chronological order, the research that was conducted during 
the testing and field pilot implementation of the probiotic. The first chapter describes the 
captive trials, with the preliminary findings which facilitated field implementation; in the 
second chapter I present the field trial application of the prophylaxis; and in the third 
chapter I describe a pilot ex-vivo Pd-challenge experiment on severed bat wings that 
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White-nose syndrome (WNS) is one of the deadliest wildlife diseases in recorded 
history and is causing devastating consequences for bat populations in North America 
(Frick et al. 2010). White-nose syndrome is caused by Pseudogymnoascus destructans 
(Pd) and has resulted in greater than 90% mortality rates in some bat roosts (Frick et al. 
2015; Lorch et al. 2011). It was introduced to the east coast of North America in 2006 
and has been spreading ever since (Frick et al. 2010, Lorch et al. 2016), including a 
giant leap of the fungus into Washington state (USFWS 2019), the only western state 
where WNS has been found to date. 
Pseudogymnoascus destructans is a psychrophilic fungus that grows optimally 
between 12.5-15.8°C and 70-81.5% relative humidity and causes mortality of 
hibernating bats (Johnson et al. 2014; Marroquin et al. 2017; Verant et al. 2012; 
Warnecke et al. 2012). Hibernating bats have arousals periods for several physiological 
reasons, however, once infected with Pd, a bat will arouse much more than usual, 
experience higher rates of evaporative water loss (EWL), and blood electrolyte 
disruption (Jonasson and Willis 2012, McGuire et al. 2017, Reeder et al. 2012, Verant et 
al. 2014, Warnecke et al. 2013). These physiological imbalances will eventually kill the 
bat because of greater energy expenditure, thus burning fat stores built up from the fall 
season. Bats will arouse from hibernation due to WNS disturbance and attempts to 
groom the fungus off of their bodies (Reeder et al. 2012). Mechanically, the fungal 
hyphae will penetrate the connective tissue of the cutaneous sections of the bat and 
cause “cup-like” epidermal erosions on the wings, among small tears and patches of 
rough skin. The hyphae will noticeably invade hair follicles, sebaceous and apocrine 
glands and regional connective tissues; while producing a noticeable opaque white 
texture among the cutaneous sections of the muzzle, wings and tail regions (Meteyer et 




If the bat has survived until spring, it will move to summer roosts where continued 
grooming, and a warm body temperature above that which Pd can survive, will reduce 
Pd spore loads to nearly zero for the duration of the reproductive period if they do not 
return to the winter roosts. The Pd fungus has been known to persist in caves because 
of the continuous lower temperature and high humidity (Hoyt et al. 2015a).  
For the most vulnerable bat species, such as Myotis septentrionalis and M. 
lucifugus, once a winter colony has been exposed to Pd there is reduced chance of 
survival; however, some populations, especially of less vulnerable species, have shown 
less infection intensity after surviving WNS (Langwig et al. 2017). Hypotheses for why 
some bats survive WNS included gene selection pertaining to immune response and 
wound healing, skin microbiota, and behavioural adaptions (Frick et al. 2017; Hazim et 
al. 2018; Langwig et al. 2017; Lemieux-Labonté et al. (2017). However, cumulative 
mortality risk models suggest that even populations of less susceptible bat species may 
follow a stabilized negative growth rate after a major mortality event (Maslo et al. 2017), 
leading to a false sense of security in the fate of some bat species. 
WNS along with other fungal diseases such as chytridiomycosis 
(Batrachochytrium dendrobatidis) and ophidiomycosis (Ophidiomyces ophiodiicola), 
which has caused rapid decline in amphibian and snake species, respectively, are 
threatening wildlife in unprecedented ways, and urgency surrounds the management of 
these diseases (Becker et al. 2015, Lorch et al. 2015). Reducing the mortality of bats 
from WNS could have important benefits for the ecosystem and economy. It is 
especially important to consider the economic benefits bats provide. They control some 
insect populations and reduce the use of pesticides in North American agriculture and 
forestry industries; without the ecosystem services provided by bats, it is estimated that 
the US could see an economic loss of 3.7-53 billion dollars a year (Boyles et al. 2011).  
A vaccine showing promising results has recently been conducted in vivo and is 
awaiting field testing (Rocke et al. 2019). However, administering a vaccine can be 
difficult on free ranging or wild animals. Administering requires consistent human 




each year, and depending on its efficacy, could require repeated vaccinations of the 
same individual. It can be expensive and could cause repeated disturbance to bats 
(Langwig et al. 2015).  
The microflora present on an animal’s skin plays a vital role in the health of the 
individual. Healthy bacteria have been proven to provide increased protection from 
pathogen colonization by increased processing of skin proteins and overall inhibition of 
invasive transient microorganisms (Clay 2014; Grice and Segre 2011). Probiotics offer 
advantages over chemical antifungal treatments, being safer and longer lasting 
(Thomas and Willis 1998, TUFTS University 2011). Traditionally, fungicides have been 
used to combat diseases in agriculture (e.g., Knight et al. 1997). Broad use of 
fungicides can be dangerous to native microbiomes and expensive (Thomas and Willis 
1998, TUFTS University 2011). However, bacteria belonging to the P. fluorescens 
species complex have been increasingly considered for biocontrol of pests in agriculture 
because of its production of bioactive metabolites and rapid growth within the 
rhizosphere (Prasad et al. 2018). Other examples of probiotics assisting with fungal 
diseases include clearing chytridiomycosis infection through bacterial control (Becker et 
al. 2015); defending crustacean embryos with symbiotic marine bacteria (Gil-Turnes et 
al. 1989); and protecting wasp larvae from fungal infection (Kaltenpoth et al. 2004).  
Anti-Pd bacteria have shown to be a promising choice for protecting bats from 
WNS mortality (Hamm et al. 2017, Hoyt et al. 2015b, Hoyt et al. 2019). Utilizing bacteria 
found on native bat species can prevent complications and assist with anti-Pd 
colonization into bat wing microbiomes (Bletz et al. 2013). Further, there is potential for 
probiotics to coevolve with the pathogen and provide long lasting solutions not seen in 
chemical fungicides (Thomas et al 1998). 
Studies using microbials to inhibit Pd include Trichoderma polysporum fungi 
(Zhang et al. 2015), and Rhodococcus rhodochrous to inhibit Pd growth when it is 
induced with urea (Cornelison et al. 2014). Three other studies have tested the 
Pseudomonas fluorescens species complex for its anti-Pd activity (Cheng et al. 2017; 




to inhibit Pd as a biocontrol agent was first proposed by Hoyt et al. (2015b). Cheng et al. 
(2016) produced mixed results, in which bacteria from the P. fluorescens species 
complex were applied in large doses to bats which were hibernated in a laboratory 
setting. Hoyt et al. (2019), applied the same probiotic in a controlled field trial at a mine 
hibernaculum, reporting obvious survival benefits from application of the probiotic -- five-
fold survival of the probiotic-treated group compared to the control group.  
We have developed a prophylaxis composed of Pseudomonas bacteria naturally 
found on bats’ wings in British Columbia, Canada. Candidate isolates were identified 
based on Pd inhibition, and combinations of isolates were previously tested for 
synergistic activity ex-vivo (Appendix A; unpublished data). Four isolates were selected 
for the final probiotic cocktail based on their mix of partial and full inhibition, and additive 
inhibition against Pd: P. azotoformans, P. synxantha strains A and B, and P. antarctica. 
The premise of our WNS prophylaxis approach is that through summer 
application of probiotic on wings, bats arrive at winter hibernacula with enhanced wing 
microbiomes containing anti-Pd probiotic bacteria. This may be able to delay or prevent 
Pd growth for a critical portion of the winter.  
Here, we test this probiotic cocktail in varying dosages, on captive free-flying 
bats. Our goals were to develop a passive method of application that could also be used 
in field applications; confirm that a sustained change in wing microbiome could be 
achieved, in which probiotic bacteria would become incorporated into the wing 
microbiome; compare temperature and probiotic cell counts on an empty bat box; and 
test the health of captive bats in ‘treatment’ and ‘control’ groups to ensure the probiotic 
caused no ill effects.  
I describe two captive trials on captive M. yumanensis bats free-flying in large 
open air enclosures during summer months – one pilot trial in 2018 and a 
comprehensive trial in 2019. The latter trial expanded into fall and early winter to include 




examined the response of our probiotic bacteria on hibernating bat in a controlled 
environmental chamber. 
METHODS 
Captive Bat Enclosures 
Two large bat enclosures were built at the BC Wildlife Park (BCWP) in 
Kamloops, located away from the public and enclosed in an area only accessible by 
employees. Each of the two enclosures were covered by a large carport to provide 
shelter from sun and weather; however, bats were still exposed to environmental 
fluctuations including changes in temperature, humidity, and wind because the ends of 
the carport was left open and the enclosures’ outer walls were constructed of wire 
mesh. A solid middle wall divided each enclosure in half, forming two flight chambers of 
equal area and design (each chamber 3.05m long x 1.37m wide x 3.05m high). The two 
enclosures were approximately 30 metres from each other. Some of the mesh walls 
were strategically covered with corrugated plastic board to reduce wind turbulence 
which could result in air exchange between sides, and to ensure that bat feeding and 
water dishes were not upset by strong gusts of wind.  All human entry was through a 
vestibule on one end of each flight chamber, and these vestibules were on opposite 
ends of the chambers to further reduce the chance of contamination. Vestibules had a 
door on each side – one for entry/exit from the vestibule to the outdoors, and the other 
door which entered into the flight chamber.  Vestibules’ outside doors were hinged solid 
wood with spring hinges for automatic closure, and the inside doors were zippered vinyl 
to ensure bats could not escape from the chamber.  A Tyvek suit, boot covers, shower 
caps, and disposable gloves were donned while standing in the vestibule so that all 
entry in and out of the chamber reduced chance of cross-contamination. Each day, the 
‘control’ bats were tended to first and then the ‘treatment’ bats to reduce chance of 
accidental introducing probiotic to the control side. There was a large Rubbermaid 
storage bin outside each vestibule which held items specific to each enclosure group. 




Each flight chamber had a single chamber bat house (with hinged front door to 
allow access to bats) mounted on the middle dividing wall for bats to roost in. On each 
end (opposite ends of each flight chamber), there was a watering dish, and a food 
station. For details on bat care see Appendix B.  
Only one enclosure had been built at the time of the 2018 pilot captive trial, and 
one flight chamber was used for the Treatment bats and the other for the Control bats. 
In 2019, we used two enclosures, one enclosure housed two groups of Treatment bats 
(Treatment 1, Treatment 2), each in their own flight chamber (Figure 2.1). And the other 
enclosure housed the Control bats, all on one side in one flight chamber. The second 
flight chamber of this enclosure was not used. A HOBO microclimate data logger (Onset 
Corporation, SN 20340415 for treatment 1 and SN 20340414 for treatment 2) was 
installed into each treatment chamber to measure temperature and relative humidity. 
Each logger had two probes: one was placed ¾ of the way into the left side of the box 
and the other probe was attached to the wall of the same enclosure within a cut-out 
yogurt container to shield it.  
 
Figure 2.1. A. Floor plan of control and treatment enclosures. The control enclosure was 






Animal Collection and Handling 
M. yumanensis bats were captured from Vernon, Chase, Greater Vancouver, or 
Creston, BC, under the permit issued to C. Lausen, WCS Canada, 287882. Each bat 
used in the trial had a colored or numbered forearm band on its wing to differentiate 
them from one another. They were taught to self-feed on mealworms and self-drink out 
of a water dishes. In 2018, 11 adult M. yumanensis were taken captive (10 males, 1 
female), and in 2019, 20 adult M. yumanensis were taken captive (19 males, 1 
females).  
Probiotic Composition 
In 2018, two synergistic strains, which were Pseudomonas strains that exhibited 
full inhibition of Pd growth in vitro were used in our pilot probiotic. Both isolates were 
sourced from a Eptesicus fuscus female adult bat from a mine hibernaculum near 
Salmo, BC. One of these strains were identified as P. synxantha strain B and was used 
in our 2019 experiment probiotic. Full inhibition isolates are characterized by their ability 
to fully inhibit Pd, which is contrast to a partial inhibitor, that only suppresses hyphal 
growth. 
In 2019, four synergistic Pseudomonas strains were included into a final probiotic: 
Pseudomonas synxantha strains A (full inhibitor) and B (full inhibitor), P. azotoformans 
(full inhibitor), and P. antarctica (partial inhibitor). Each isolate was previously sourced 
from bats in BC. Pseudomonas synxantha strain A was isolated from a M. yumanensis 
at a mine hibernaculum near Salmo, British Columbia; strain B was isolated from an 
adult female E. fuscus captured free-flying at a mine near Salmo, BC (as told above); P. 
azotoformans was isolated from an adult Corynorhinus townsendii caught from a 
maternity roost in Deroche, British Columbia; and P. antarctica was sourced from a 
female juvenile M. evotis at from a mine hibernaculum near Nelway, BC. 
Probiotic strains were made in large quantities and pelleted and lyophilized using 




hours at -50°C. Viability and inhibition of probiotic cocktail was confirmed after the 
freeze-drying process. Dry pellets were ground into a fine powder using a sterile pestle. 
In 2018, probiotic was applied directly to bats’ wings in sterile water using a 
pipette and in 2019, probiotic was instead applied by freeze drying bacteria and 
combining it with sterile potter’s clay. Two hundred and fifty million Colony Forming 
Units (CFU) of each bacterium were used as a cumulative dose of about 1 billion cells 
for each dosage. Each dose was applied with sterile water onto each bat house to 
reactivate the freeze-dried bacteria.  
Development of Probiotic Application 
An application method for the four probiotic bacteria underwent different revisions 
throughout the 2019 trial. The first method incorporated a combination of our bacteria 
directly with water before application. 1 billion lyophilized cells were combined with 
275mL of sterile water and sprayed onto the Treatment 1 bat house on April 26th. Bats 
were removed from their bat house and placed into sterile cotton bags before removing 
their bat house from the treatment chamber. The bat house was put flat onto the ground 
and the door was opened to expose the roosting chamber. A hand pump sprayer was 
used to apply the probiotic-water solution evenly onto the bat house chamber. 
Afterwards, the bat house sat overnight until it was dry and re-established within their 
treatment enclosure. A different sterile bat house was used as a substitute.   
Water and clay were added separately for the second application method and 
were used in a two-step process. Bats were removed from their bat box and placed into 
cloth bags during the inoculation. The bat box was removed and sprayed with a minimal 
amount of sterile water evenly over the entire surface. The probiotic was prepared in 
sterile potter’s clay and spread evenly over the bat box within the enclosure. After ten 
minutes the bat box was placed into the same location previously and bats were placed 
back into the box. Bacteria amounts were consistent for repeated doses, however 
different amounts of clay and water were utilized for our Treatment 1 bat house in order 




on May 12th and 24th, 50mL water and 30g clay on June 24th, and 29th. The 
Treatment 2 bat house received the same later dosage on June 15. Finally, two 
dosages of 1 billion cells were applied to our treatment 2 captive bat boxes on 
September 30th and October 7th before acclimation began on November 3rd for the 
hibernation experiment. The method of applying water and then powered clay became 
the final application method used, although there was further work done on how to 
create a sprayer to put clay powder up into bat box chambers in the field where 
chambers are vertical and cannot be accessed via a door as they were in the single 
chamber bat boxes used in the enclosures (see Chapter 3 methods). 
Figure 2.2. Timeline of probiotic application and euthanasia of Treatment 1, 2 and 
Hibernation groups. *Bats remained in outdoor enclosure throughout September and 
October. 
Four-chambered Bat Box 
In 2019, a four-chambered bat box (Chamber 1 directly above landing platform; 
Chamber 4 was furthest from the landing platform) was treated with probiotic-laden clay, 
just as were the single-chamber bat boxes within each enclosure’s flight chamber. 










































based bat box for wild bats. The bat box was hung 3m off the ground and faced the 
sunset (west) starting May 17th, 2019. A HOBO microclimate datalogger (Onset 
Corporation, SN 20577875 for chamber 1, SN 20577881 for chamber 2, SN 20577876 
for chamber 3, and SN 20569683 for chamber 4 ) was placed into each chamber of the 
bat house to measure temperature and relative humidity (chamber 4’s sensor recorded 
temperature only). This box’s entrance was screened off to prevent it from being used 
by wild bats in the area; probiotic concentrations and internal microclimate were 
measured throughout the summer. 
The loggers were strategically placed for different experiments: initially at a depth 
of 15.25cm from May 17th-July 14th for the first experiment, and 30.5cm into the box 
from July 14th until the end of the trial for the second experiment. Each chamber was 
inoculated with a ‘dose’ of probiotic clay powder and a clay paste on May 23rd, both of 
which were 15.25cm deep into the bat box (Figure 2.3). On July 20th a second powder 
treatment was inoculated deeper within each bat box chamber at 30.5cm. Each 
treatment was separated and swabbed individually by chamber each week until the end 
of August. 
 
Figure 2.3. A. Four-chamber bat box hanging off the ground and away from our captive 
bat enclosures. B. Clay paste application (left), powder application (right) within the four-







Figure 2.4. Timeline of four-chamber bat box experiment. 
 
Sampling of Microbes from Wings and Roost Substrates 
Treatment 1 group of captive bats were swabbed with sterile polyester tips from 
April 28th until July 8th. The second treatment group was swabbed from June 15th until 
August 24th. Finally, the hibernation trial bats were swabbed from November 16th to 
December 21st. Swabs were performed once a week to prevent bat stress and 
interference with treated bats microflora. Each bat was individually swabbed by rolling 
the polyester tip evenly onto the bat’s wings.  
 Swabbing protocol evolved as the experiment proceeded and this meant that 
Treatment 1 bats were swabbed differently throughout the trial. Wing area was mapped 
by measuring left and right arm length (see Appendix C). On May 26th and June 1st, 
the ventral and dorsal side were swabbed together. One swab constituted both wings, 
wing tip to armpit along the wing membrane, on one side of the bat (ventral or dorsal). 
One swab for both wings, wingtip to armpit on the dorsal side, were used permanently 
from June 8th until the end of the trial. 
Bats from the hibernation trial were removed from the cooler every 7-10 days to 
























heat pads for approximately 5 minutes before food and water were offered. A polyester 
swab was rolled along the top portion of one wing from tip to armpit. Left and right wings 
were alternated when swabbing to prevent accidental rubbing off of probiotic from 
previous swabbing. We swabbed along the myotis finger bones. Each week a different 
fingerbone was used. polyester swab tips were broken off into Eppendorf tubes 
containing 1mL of sterile water and were immediately transported to the lab.  
Processing of Swab Samples 
Using sterile polyester-tipped swabs, bats and roost substrates were periodically 
sampled to quantify presence of each probiotic bacterial strain using qPCR. Custom 
probes were designed specific to each bacterial strain. Upon swabbing of bat wings or 
roosting substrates, swabs were immediately placed into Eppendorf tubes, refrigerated, 
and shipped for qPCR analysis at McMaster University. In 2018, the wing area for each 
bat was measured using photography and subsequent calculation of area 
(SketchAndCalc 2021). Subsequent analyses showed no significant difference among 
wing areas, and thus for 2019, mean swabbing areas were used to calibrate all cell 
concentration for wings depending on swab location (/cm2; see Appendix C for 
measurements and dates used).   
An additional test of viability on our samples was introduced on June 8th until the 
end of the trial. This test required the swab sample to be split: each Eppendorf vial 
containing a swab was vortexed on medium-high for 20 seconds and the tips were 
removed from the water inside the tube. The remaining 1mL was divided into a separate 
Eppendorf containing 1mL of LB broth, and the remaining water was frozen. The LB 
broth containing half our sampled cells were placed onto a shaker at 25oC on medium 
for 12 hours. Afterwards the broth was frozen and transported to McMaster University 
alongside our original frozen water samples for qPCR analysis. The surface area was 
measured of each wing section to account for differences in inoculated area.  
Collaborative researchers at McMaster University used the following protocol for 




were used to quantify cell concentrations in each swab compared to background levels. 
Swabs tips were washed with PBS in sterile tubes and vortexed. This suspension was 
then sonicated for 30 seconds in a sterile glass vial. Standards were created through 
serial dilution of  cells (105, 104, 103, and 102) which were prepared identically to wing 
swab samples. All reactions were carried out in triplicate containing: 10μl of 2X NEB 
Luna qPCR (SYBR green dye), 0.5μL of each primer at 10μM, and 2μL of sonicated 
cells. Reactions were run on a BioRad CFX96 machine (Mississauga, Ontario). Initial 
denaturation was performed at 95°C for 2 minutes, followed by 40 cycles of additional 
denaturation at 95°C for 30 seconds and annealing/extension for 30 seconds at 60°C. 
Using CFX Manager software (V3.0) a standard curve was created using the Cycle 
Threshold (Cq) values from samples of known concentration of cells. Fitting the Cq 
values from samples of unknown concentration allow for us to extrapolate the number of 
cells present in each swab. These swabs  were corrected for the average wing 
area. Standard error was calculated for all means. See appendix G for sample sizes 
and details on mean and error calculations. Unfortunately, due to unreliability with the P. 
antarctica probe, only some of the samples managed to be salvaged and presented 
appropriately.  
Hibernation Trial 
Three M. yumanensis bats from our previous captive trial were acclimated into 
the hibernation chamber gradually over 5 days, followed by another decrease of 1oC 14 
days later (see Appendix D for environmental chamber conditions). A modified glass-
door wine fridge of approximate dimensions was used as a hibernation chamber: width 
of 59.4cm, height of 85.6cm and depth of 62.5cm (Figure 2.5). The fridge was 
maintained at a temperature of 4.5-8oC throughout the trial, using a digital thermostat 
controller which was accessible on the outside of the fridge. Internal humidity was 
measured and controlled to range between 90-100% humidity by using a terrarium 
humidifier (Zoo Med Reptile Fogger) ; humidity control was automated using a humidity 
controller (Inkbird) to replicate M. yumanensis hibernating environmental conditions. A 




powered the humidifier when humidity dropped below 90%. Temperature and humidity 
were monitored using a HOBO microclimate monitor (SN 20577876) and conditions 
were modified upon observation.  
Mesh screen lined the fridge to allow bats to move around in the chamber. A 
cloth roosting pouch, a tin food dish, and a small water dish (with marbles and sponge 
to prevent drowning) were placed into the hibernation chamber. A wide-angle infrared 
camera (Model number: GXLFPW7WE58LHJS2111A) was placed into the chamber 
which enabled monitoring of the bats without disturbance. Video footage was automated 
and could be accessed via a smartphone app (iCookyCam). The glass door of the fridge 
was covered with a thick blanket to keep out light, and the room housing the fridge was 
kept dark. An oxygen tank was connected by an external hose which reached into the 
chamber; oxygen was monitored using an oxygen sensor and air levels were manually 
maintained between 19-24% oxygen using an external air tank. An oxygen monitor was 
installed inside the chamber. Once every ~10 days the door of the fridge was opened, 




Figure 2.5. A modified beverage cooler was converted into an environmental chamber 
for the bat hibernation experiment. The temperature and humidity were controlled by a 




retain >90% relative humidity. A wireless camera was installed to view the bats and 
record activity. The roost pouch and food were removed shortly after acclimation. 
Necropsies and Histology 
All captive bats were ultimately euthanized (see figure 2.2 for dates). Necropsies 
and wing tissue histology (n = 9 bats in 2018; n = 13 bats in 2019) were conducted by 
Dr. Glenna McGregor (BC Animal Health Lab, Abbotsford, BC examined skin of wings, 
ears, nose and tail looked for the following potential pathologies:  acanthosis, bacterial 
epidermal, bacterial invasion, dermal inflammation, epidermal inflammation, 
hemorrhage, hyperkeratosis, hyphae, mites, monocytes, overall inflammation, rabies, 
segs (mature neutrophiles), ulceration and yeast). 
 
RESULTS 
Swab Sample Results - 2018 Pilot 
From wing samples taken at the start of the 2018 pilot captive trial, we detected 
large quantities of the probiotic strains on bats from the treatment side of the enclosure 
(Figure 2.6B). The probiotic abundance on samples taken from the control side of the 
enclosure was low at first, but increased over time, increasing to levels similar to that of 
treated bats (Figure 2.6A), providing conclusive evidence of cross-contamination, likely 
through probiotic travelling in the air between sides of the enclosure during spraying of 
probiotic on treatment bats. As such, the wing concentrations from the 2018 captive bat 
trial were not used in further analyses, and are presented here (Figure 2.6) only to 
provide context for the necropsies and histology examination. Refinement of methods 
from the 2018 trial informed the 2019 captive trial, including the building of a separate 
























A)                                                                             B)                                                                    
 
Figure 2.6. A) The number of probiotic cells detected on treated bats was determined 
using qPCR of wing swabs, relative to pre-exposure concentrations, corrected by wing 
area. B) The number of probiotic cells detected on control bats using qPCR of wing 
swabs, corrected by wing area. Each colour is one individual captive bat. Figures 
prepared by Adrian Forsythe. 
2019 Captive Summer Trial 
Baseline and control swabs 
Concentrations of each probiotic bacteria were quantified on every bat when they 
were first introduced into captivity on April 21st (Figure 2.7). Background levels of all 
three probiotic bacteria were detectable from their wings and averaged to find a mean. 
There were 4.99 ± 1.21 cells/cm2 (31 replicates) of P. synxantha B, 88.4 ± 19.9 
cells/cm2 (n=30 replicates) of P. synxantha A, and 1.62 ± 0.37 cells/cm2 (n=21 
replicates) of P. azotoformans. Probiotic bacteria was found on the control bat box 
throughout the captive trial however it was very low relative to the treatment bat boxes 






Figure 2.7. Number of probiotic cells present on captive bats on April 21st, before 
probiotic application began. Note the logarithmic scale. 
 
Figure 2.8. Number of probiotic cells present on the control bat box throughout the trial. 

























































The broth results were dropped from our analysis because of too many 
confounding variables and randomness of the data. Factors that lowered the reliability 
of our results included: competing microbes growing in the broth, only incubating the 
samples for 12 hours, and inability to reliably split a suspension 50/50 in terms of cell 
count. Results for the broth test are found in Appendix E.  
Treatment 1 
Concentrations were measured on bat wings from May 26th until June 29th. 
Concentrations of each bacteria followed a similar trend and P. synxantha A was 
significantly higher throughout the trial than P. azotoformans and P. synxantha B 
(Figure 2.9) per cm2 of bat wings. P. synxantha A ranged between 5.95 ± 3.77 x102 to ± 
4.88 ± 2.57 x105 cells/cm2 throughout the trial and was consistently at least ~15 times 
higher in concentration if we do not consider the similar concentrations of P. synxantha 
A and P. synxantha B on June 1st. Concentrations of the other 3 bacteria ranged from 
19.1 ± 12.4 cells/cm2 (P. azotoformans strain B on June 1st) to 1.74 ± .904x104 cells/cm2 
(P. synxantha B on May 26th).  
Bat box concentrations (figure 2.10) show a similar pattern seen in the bat 
swabs, in which P. synxantha A was much higher than the other two probiotic bacteria 
in quantity. P. synxantha A cell concentration ranged between 1.95 ± ,144 x104 
cells/cm2  to 3.95 ± .197 x104 cells/cm2 throughout the trial period. The other three 
bacteria ranged from 563 ± 32.5 cells/cm2  (P. azotoformans on June 1st) to 2.08 ± .12 
x103 cells/cm2 (P. synxantha B on June 8th). The concentration of P. synxantha A was 
consistently at least ~18.5 times higher than the other two bacteria concentrations on 






Figure 2.9. Starting quantities of probiotic cells detected on treated bats in the 
Treatment 1 group using qPCR for each probiotic bacteria species. Concentrations are 
corrected by wing area to represent cm2. Note the logarithmic scale. 
 
Figure 2.10. Concentrations of probiotic cells detected within the bat box in the 
Treatment 1 group using qPCR for each probiotic bacteria species. Concentrations are 
























































Enclosure and bat box temperatures were compared between Treatment 1 and 
Treatment 2 groups for any significant differences. The temperature of each enclosure 
and bat box within treatment group 1 and 2 were measured from May 12th until August 
7th (n=41,601 for each location and treatment group). There were no significant 
differences between enclosure temperatures (19.1 ± 0.03 oC treatment 1; 19.00 ± 0.03 
oC treatment 2; P>0.05), however, bat box temperatures were significantly different 
(19.6 ± 0.03 oC treatment 1; 19.4 ± 0.03 oC treatment 2; P<0.05). The significant 
difference is very small with a mean difference (T1-T2) of 0.190 ± .001 oC. 
Treatment 2 
Concentrations were calculated based on area of the skin in cm2 and a mean 
was found between all bat wing swabs. Bat swabs taken from the Treatment 2 group 
have a detectable concentration of each species throughout the trial from June 29th 
until August 14th (Figures 2.11). P. synxantha A was overall the most abundant among 
each probiotic species, however relative concentrations between the probiotic species 
are mixed. P. synxantha A had a range of 13.6 ± 8.63 cells/cm2 to 667 ± 0 cells/cm2 and 
was only significantly higher than the other 3 bacteria on July 13th and August 9th (at 
least ~19 times higher). The other 3 bacteria ranged between 12.7 ± 0.86 cells/cm2 (P. 
antarctica on August 9th) and 1.36 ± 1.35 x103 cells/cm2 (P. azotoformans on August 
14th) 
Treatment 2 bat box swabs showed an abundant probiotic concentration 
throughout the trial since application on June 13th (Figure 2.12). P. synxantha A ranged 
between  1.68 ± .81 x104 cells/cm2 to 3.99 ± 2.07 x104 cells/cm2 and was consistently at 
least ~18 times higher than the other bacteria species. Each of the other three probiotic 
species ranged between 91.2 ± 42.5 cells/cm2 (P. antarctica on August 18th) and 2.17 ± 





Figure 2.11.  Starting quantities of probiotic cells detected on treated bats within the 
Treatment 2 group using qPCR for each probiotic bacteria species that was frozen in 
H2O. Note the logarithmic scales. 
 
 
Figure 2.12. Starting quantities of probiotic cells detected on the bat box within the 
Treatment 2 group using qPCR for each probiotic bacteria species that was frozen in H2O. 
























































Four-chamber Bat box 
The probiotic bacteria were still detectable using qPCR when exposed to 
summer heat within the four-chamber bat box three months after original application, 
from July 20th until August 24th (Figure 2.13). The results from the paste application 
were excluded due to small amounts of detectable bacteria found immediately after 
application. All chambers were combined to form a mean of detectable bacteria found in 
the four-chamber bat box across all chambers for each date swabbed. This allowed us 
to look for general trends across all samples of our data. 
P. synxantha A was significantly more abundant than P. synxantha B, P. 
antarctica, and P. azotorformans, which all had similar quantities throughout the trial. 
Results are similar to the bat box results for treatment 1 and treatment 2. In which P. 
synxantha A is approximately 18.5 times higher than other individual probiotic bacteria 
species across all sampling dates except for June 9th, in which it is only 4.4 times 
higher. P. synxantha A concentration ranged from 9.73 ± 1.88 x103 to 1.58 ± .860 x105 
cells/cm2 throughout the trial, whereas the other 3 bacteria ranged from 23.9 ± 7.26 







Figure 2.13. Concentration of probiotic cells detected in combined chambers of the four-
chamber bat box using qPCR for each probiotic bacteria species frozen in H2O. Note 
the logarithmic scales. 
 
Daily temperatures within each chamber averaged between 15.78oC-33.75oC 
across the entire monitoring period (Figure 2.14). Chamber 4 (front chamber) exhibited 
the highest average daily temperature from the end of July and into August, however 
none of the chambers average values were significantly different throughout the trial 
period (P=0.456; Table 2.1 ). Chamber 1 had a statistically significantly higher maximum 
daily temperature when compared to chambers 2, 3 and 4 (P<0.001) (Figure 2.15) 
throughout the trial period. The maximum temperatures seen in chambers 1-4 were 
57.4oC, 49.7oC, 49.5oC, and 51.8oC, and the minimum daily temperatures were 5.5oC, 
6.3oC, 6.5oC, and 6.4oC, respectively. Chamber 1 had a significantly higher maximum 
temperature than other chambers (P<0.05; Table 2.2). We saw no significant 
differences in average daily relative humidity or minimum temperatures among 
chambers (P>0.5) (results not presented). 
 
Individual chambers differed significantly in probiotic concentrations (table 2.3). 































bacteria concentrations are compared, P. synxantha A was the only significant probiotic 
bacteria (P<0.05), whereas P. azotoformans, P. synxantha B, P. antarctica are not 
significantly different from each other (P<0.05). 
 
Figure 2.14. Average daily temperature for each chamber of the four-chamber bat box 





































Table 2.1. One Way Analysis Of Variance and Post Hoc test between each chamber of 
the four-chamber bat box comparing average daily temperature. Means that do not 
share a letter are signficantly different.  
Analysis of Variance for Average Daily Temperature 
Source DF Adj SS Adj MS F-Value P-Value   
Factor 3 46.41 15.47 0.87 0.456   
Error 268 4756.41 17.75 
  
  
Total 271 4802.81 
   
  
  
     
  
Factor N Mean StDev 95% CI   
Chamber1Mean 68 23.638 4.01 (22.633, 24.644)   
Chamber2Mean 68 23.345 4.138 (22.339, 24.351)   
Chamber3Mean 68 23.525 4.185 (22.519, 24.531)   
Chamber4Mean 68 24.426 4.503 (23.420, 24.431)   
  
     
  
Grouping Information Using the Tukey Method and 95% Confidence 
Factor 
 
N Mean Grouping   
Chamber4Mean 68 24.426 A 
 
  
Chamber1Mean 68 23.638 A 
 
  
Chamber3Mean 68 23.525 A 
 
  







Figure 2.15. Average daily maximum temperature for each chamber of the four-






































Table 2.2. One Way Analysis Of Variance and Post Hoc test between each chamber of 
the four-chamber bat box comparing daily maximum temperatures. Means that do not 
share a letter indicate statistically signifcant differences.  
Analysis of Variance for Maximum Daily Temperature 
Source DF Adj SS Adj MS F-Value P-Value   
Factor 3 1349 449.71 8.28 0.000   
Error 268 14557 54.32 
  
  
Total 271 15906 
   
  
  
     
  
Factor N Mean StDev 95% CI   
Chamber1Mean 68 23.638 4.01 (22.633, 24.644)   
Chamber2Mean 68 23.345 4.138 (22.339, 24.351)   
Chamber3Mean 68 23.525 4.185 (22.519, 24.531)   
Chamber4Mean 68 24.426 4.503 (23.420, 25.431)   
  
     
  
Grouping Information Using the Tukey Method and 95% Confidence 
Factor 
 
N Mean Grouping   
Chamber1Mean 68 24.426 A 
 
  
Chamber4Mean 68 23.638 B 
 
  
Chamber2Mean 68 23.525 B 
 
  











Table 2.3. General Linear Model for details of frozen water samples on chamber, 
bacteria species, and interactions between the two. Means that do not share a letter 
indicate statistically signifcant differences. 
Analysis of Variance for Frozen Water Samples 
Source DF Adj SS Adj MS F-Value P-Value 
Chamber 3 28.723 9.5743 15.06 0.000 
Bacteria Species 3 79.773 26.591 41.84 0.000 
Chamber*Bacteria Species 9 1.142 0.1269 0.2 0.994 
Error 171 108.683 0.6356 
 
  




    
  
Tukey Method and 95% Confidence 
 
  
Chamber N Mean Grouping   
1 47 4.23486 A 
 
  
2 46 3.64363 B 
 
  
3 47 3.40292 B, C 
 
  




    
  
Bacteria Species N Mean Grouping 
 
  
P. synxantha A 48 4.72339 A 
 
  
P. synxantha B 48 3.44183 B 
 
  
P. azotoformans  48 3.18439 B 
 
  
P. antarctica 43 3.12017 B     
 
Bat Box Probiotic Comparison 
P. synxantha A has a higher ratio of cell abundance compared to other probiotic 
bacteria found within each bat box (Table 2.4). When the ratio of P. synxantha to the 
average value of other probiotic bacteria is tested, an increase in concentration of P. 
synxantha is seen over time. Treatment 1 bat box P. synxantha A concentration 




from July 13th to August 9th, and the four-chamber bat box increased by 8.3% from July 
20th to August 24th.  
Table 2.4. Ratio of P. synxantha strain A to all other probiotic bacteria found within the 
bat box, from first swabbing date to last. A higher ratio signifies greater abundance of P. 
synxantha A to other probiotic bacteria.  
Treatment 1 Bat Box (P. synxantha strain A)/((P. synxantha B + P. azotoformans/2)) 
2019-06-01 24.3 
2019-06-15 25.3 
    
Treatment 2 Bat Box (P. synxantha strain A)/((P. synxantha B + P. azotoformans+P. antacrtica/3)) 
2019-07-13 32.0 
2019-08-09 34.9 
    





Hibernation Captive Trial 
Primers specific to each of the probiotic species were used to quantify the 
abundance of probiotic present on wing tissue throughout the hibernation trial. Bats 
were not exposed to probiotic bacteria since the application dates of September 30th 
and October 7th. Results suggest that each of the probiotic species stabilized in 
concentration throughout the testing period from November 16th until December 21st 
(Figure 2.16). However, P. synxantha largely dominated with a higher concentration and 
was ~18 times higher than the other individual bacteria concentrations except for the 
last swab on December 21st. Detectable concentrations of each bacteria significantly 
dipped in concentration on December 18th but returned to previous levels on December 
21st, in which P. antarctica reached 6.95 ± 3.9 x109 cells/cm2 and trumped P. synxantha 
A by 141,919-fold. Each bacteria species significantly increased in concentration from 




4.66x106 fold higher in comparison to the other bacteria which increased ~14 fold from 
their starting quantities, although this could be an outlier in the data (Table 2.5). This 
increase suggests that the probiotic bacteria were proliferating on the captive bat wings 
during hibernation when exposed to the high humidity and low temperature conditions. 
Captive myotis body weights slowly decreased throughout the trial and can be attributed 
due to their disturbance from weekly swabbing and artificial hibernating conditions. Bats 
were largely torpor throughout the hibernating conditions but were removed once they 





Figure 2.16. Concentration of probiotic cells detected on treated bats using qPCR for 
each probiotic bacteria species after being placed in sterile water and 
immediately frozen. Cell concentrations are corrected by wing area to represent cm2. 





































Table 2.5. Concentrations of probiotic detected on bats in hibernation chamber, at the 
start and end of the 35 day experiment. Concentrations (adjusted by wing area, cm2) 









1.56 ± .186 x103 
(.691 - 2.32 x103) 
2.79 ± ,337 x104 
(1.24 - 4.1 x104) 
870 ± 103 
(.395 - 1.3 x103) 
1.49 ± .096x103 




2.24 ± .148 x104 
(1.88 - 2.82 x104) 
4.11 ± .275x105 
(3.27 - 4.96 x105) 
1.08 ± .081 x104 
(8.72 - 1.37 x104) 
6.95 ± 3.9 x109 
(8.35x101 -2.02x1010) 
Fold increase 14.4 14.7 12.4 4.66x106 
 
Necropsies and Histology 
Fall Trial 
Necropsies were performed by Dr. Glenna McGregor, BC Animal Health Lab. A 
summary of microscopic test scores from the fall captive trial (Appendix F) reveals that 
most of the bats that remained in captivity until the end of the trial period showed overall 
high scores (negative health), ranging from 9 - 94 (mean = 46; n = 6).  Bats that died 
prior to the end of the trial and were thus only in captivity for less than 1 month, showed 
overall lower scores (better health), ranging from 1 – 13 (mean = 5.3; n = 3), and 
showing overall less inflammation. In general, G. McGregor commented that the 
inflammation was higher in all bats that were examined in contrast to what she would 
typically see in wild bats; this included more acanthosis (thickening of the skin), 
potentially due to repeated swabbing. Bats that were euthanized at the end of the trial 
were examined for neutrophils in the lung and spleen and it was found that there was a 
large number of these indicative of a systemic inflammatory response (G. McGregor, 
pers. comm.), but also commonly associated with a response of hibernators when 
entering deep bouts of torpor (Bouma et al. 2010).   




Summer Captive Trial 
 Necropsies performed on the control group were compared to the Treatment 1 
group. Wings, ears, tails, noses, lungs, spleens were examined for a lengthy number of 
histology criteria (Appendix F) such as inflammation, neutrophil and monocyte count, 
acanthosis and hyperkeratosis. Results were similar to the fall trial histology 
examination; however, the control bats more closely resembled the treatment bats 
based on criteria and no significant differences were found between the two groups 
(P>0.05; not shown here) when a General Linear Model is used to compare histology 
criteria (Appendix F). The only significant outlier was dermal inflammation in the tail 
(P=0.045), in which the control had more inflammation than our treatment group, which 
is a negligible finding and is likely due to handling.  
DISCUSSION 
We saw no detrimental effects from the prophylaxis application in two separate 
captive trials and the probiotic can easily be transported and implemented using the 
clay substrate with freeze dried cells application method that we developed. Probiotic 
bacteria were persistent and presumably viable on captive bats and bat boxes months 
after application, particularly P. synxantha A, including when exposed to high summer 
heat in the 40-50oC range, and substantially increased in viability and growth when 
exposed to environmental conditions in the hibernation trial. P. synxantha A abundance 
was significantly higher in treatments 1 and 2 and the four-chamber bat box, whereas P. 
antarctica was significantly higher at the end of the hibernation experiment.  
Solutions are urgently needed to prevent WNS infection from inevitably causing 
bat mortalities in Western Canada. Pd infection has not been officially documented in 
British Columbia (WNS 2019), however, bat mortalities due to WNS are already evident 
in Washington state (WDFW 2021). M. septentrionalis is threatened and other bat 
populations could collapse without human intervention (Frick et al. 2015). British 
Columbia has the largest number of bat species in Canada, and thus stands to lose 




WNS treatment methods on live bats, and fewer have investigated use of bacteria 
antagonistic against Pd (Cheng et al. 2016; Hoyt et al. 2019). This study is the first one 
to test an anti-Pd probiotic cocktail on captive bats in summer on free-flying bats.  
I describe the cellular concentration of bacteria on wings in relation to length of 
time swabbing – in summer (captive enclosures roosting in bat boxes) and winter 
(hibernation chamber) conditions. There is a clear pattern in probiotic bacteria numbers 
that I describe. I also describe the relationship between roost microclimate temperatures 
in the four-chamber bat box in relation to changes in bacterial concentrations on 
roosting substrates. We determined that the final probiotic cocktail is safe to use, having 
found no negative effects on the health of bats associated with its application.  
Treatment 1 probiotic bat swab concentration decreased by more than half from 
the May 26th to June 15th samples. By June 15th, bacteria concentrations were 6.62 ± 
6.5 x103 cells/cm2 for P. synxantha B (62% lower), 1.0 ± .98 x105 cells/cm2 for P. 
synxantha A (79.5% lower), and 3.66 ± 3.59 x103 cells/cm2 for P. azotoformans (55.6% 
lower). The treatment 2 probiotic bat swab concentrations changed in concentration 
from June 29th to August 14th with final concentrations of 77.0 ± 75.2 cells/cm2 for P. 
synxantha B (31% lower), 58.4 ± 24.1 cells/cm2 for P. synxantha A (4.29x higher), and 
1.36 ± 1.35 x103 cells/cm2 for P. azotoformans (23.2x higher). The standard error is 
quite large for some values which is because of the large variability seen in the qPCR 
triplicate values of each swab. The larger values in treatment 1 bats are likely because 
of the multiple treatments and revisions of probiotic application they underwent on April 
26th, May 12th, and May 24th. Therefore, it is likely that treatment 1 bats had a 
background concentration of probiotic from their previous treatments leading into May 
26th, when their probiotic concentrations were highest. Treatment 2 bats were only 
exposed to one probiotic application on June 15th and have a relatively lower 
concentration. These results encourage the use of multiple treatments to increase 
probiotic bacteria concentration on bat wings. Overview on experimental design and 




Concentration of probiotic species are comparable between the treatment 1 and 
2’s bat box and the four chamber bat box, and each species appears to follow a similar 
trend of relative concentrations. P. synxantha A consistently hovers between 1x105 to 
1x106 cells/cm2 in the treatment 1 and 2 and four-chamber bat box. P. synxantha A has 
nearly always remained approximately 18 times higher in concentration than the other 
species (~18.5 fold for treatment 1, ~18 fold for treatment 2, and ~18.5 fold for the four 
chamber bat box). This contrasts with P. antarctica, which appears to have the lowest 
abundance in bat boxes and on bat wings relative to the other probiotic bacteria except 
for the hibernation trial. Arguably this pattern suggests that P. synxantha A is either 
proliferating within the bat boxes and on the bat wings, or is dying off at a slower rate 
than the other three bacteria. A clear pattern is evident from the data that P. synxantha 
A is outnumbering each of the other three probiotic bacteria, which all show similar 
values. This idea is further promoted by table 2.4 when we see an increase of P. 
synxantha A’s ratio to other bacteria from start to finish.  It is difficult to determine the 
specific reason or variables for this difference, but it may be due to differences in 
generation time and/or resilience of environmental factors such as temperature, 
moisture, and pH. 
There are many factors that can influence the growth and proliferation of 
bacterial strains on bat skin, however, they are largely unknown, particularly for this 
study. Weather, nutrients, humidity, where bats were sourced, grooming behaviour, and 
other competing microbes are all covariates that could influence the results. The 
microbiota likely varied significantly between our treatment bats and interacted in 
unknown ways with our probiotic treatment. Bats were captured from different locations 
and previous research has shown that microbiota can vary between populations 
significantly (Avena et al. 2016; Lemieux-Labonté et al. 2016; Winter et al. 2017). 
Further study is warranted to examine what constitutes ideal growing conditions of the 
probiotic bacteria on bat wings. For example, what conditions promote  anti-Pd 
antifungal compounds to be secreted when Pd is present within the environment? Clay 
has been shown to promote biofilm in Pseudomonas bacteria (Alimova, et al. 2009). As 




might additionally act as nutrient supplementation. This might in fact be essential to the 
production of secondary metabolites and thus the efficacy of this treatment (Duffy and 
Défago 1999). Testing the proliferation and persistence of the probiotic on bat box 
substrates in absence of clay, would be needed to determine this. 
The four-chamber bat box had a larger abundance of P. synxantha A than the 
other probiotic bacteria. When the chamber data is pooled (figure 2.13), there is an 
obvious trend of P. synxantha A being significantly larger than the other 3 probiotic 
bacteria as seen in treatment 1 and 2 bat boxes. This result is replicated when each 
chamber is looked at individually and P. synxantha A is still the highest (Table 2.3). 
However bacteria concentrations significantly (P<0.001) differed between individual 
chambers of the four-chamber bat box and each bacteria species (Table 2.3). 
Concentrations of all probiotic bacteria remained stable from July 20th until the end of 
the trial on August 24th. Each chamber significantly differed from at least one other 
chamber, with the largest difference being between the deepest one, chamber 1, and 
the outside one, chamber 4. Variables such as humidity, average daily temperature, and 
minimum daily temperatures were all similar (P>0.05) however chamber 1 had 
significantly hotter maximum daily temperatures when compared to chamber 2, 3 and 4 
throughout the entire trial (P<0.001). Interestingly, chamber 1 had a significantly higher 
concentration of probiotic bacteria than chambers 2,3 and 4 (P<0.001). Based on the 
humidity and temperature variables we tested, bacteria proliferation and viability 
increased when maximum temperatures increased within the bat box. Furthermore, the 
lowest maximum temperatures seen were in chamber 4, although not a significantly 
different temperature in comparison between chambers; this chamber had a 
significantly smaller number of bacteria. The only correlation that is evident from the 
data, based on the variables we tested, is that the higher maximum temperature may 
have encouraged probiotic bacteria growth based on the significantly higher abundance 
of probiotic bacteria, whereas a lower maximum temperature decreased abundance of 
probiotic bacteria. In the future, a controlled laboratory experiment that tested different 




There are many variables that may have interfered with these results such as weather, 
UV light, and overall sun exposure to each of the chambers.  
Histology scores between Treatment 1 and the control group were not 
significantly different. I can therefore conclude that there are no negative effects from 
the probiotic application that hindered the treatment bats when compared to the control. 
Although both groups had what was thought to be more inflammation than wild bats, 
captivity is likely to explain this (G. McGregor, pers. comm.).  Additionally, bats from the 
pilot trial had increased numbers of neutrophils in the lungs and spleen, but these bats 
were euthanized shortly after cold fall temperatures set in (November, when bats were 
using long bouts of torpor and likely preparing for hibernation). Leukocytes are less 
commonly found in the blood when bats are torpid; instead, immune system cells will 
move into organs to support torpor once bats transition into hibernation (Bouma et al. 
2010).  
Because the higher wing cell concentrations occur shortly after bat box 
inoculation (Figure 2.9), in field use with wild bats, we would recommend applying the 
probiotic late in the summer season, close to the time when bats leave maternity roosts 
for their hibernacula. However, there are other considerations that just be made such as 
frequency and timing of bat visits to inoculated roosts (roost switching) and thus it might 
actually be better to inoculate well before the end of summer (see next chapter), with 
optional reinoculation of roosts as opportunity allows. Even if wing concentrations at the 
end of summer are low when bats leave their maternity roosts, results of our hibernation 
experiment are encouraging, showing at least a 12.4-14.7 fold increase (Table 2.5) in 
probiotic cells within ~ one month of hibernation for P. azotoformans, P. synxantha A 
and B, and as such, even small concentrations of probiotic on bats entering into 
hibernation may be enough to protect bats from Pd growth. Unsurprisingly, P. antarctica 
grew to extremely significant concentrations by the end of the trial and was 4.66x106 
times higher with a final concentration of 6.95 ± 3.9 x109 within a single month. However 
this large increase may be because of the final value being an outlier. Concentration of 




may consider utilizing only P. antarctica for probiotic applications that occur in late fall 
before bats leave for hibernation because of its psychrophilic characteristics. We did not 
perform a histological examination of the hibernation bats however, they did not differ in 
behaviour throughout the experiment.  
In conclusion, the probiotic we have developed is safe to use on bats, can be 
successfully transferred to bats’ via their roosting substrates, and presents promise of 
preventing WNS disease in hibernating bats. P. synxantha A and P. antarctica are 
promising probiotic bacteria because of their distinguishably high concentrations in 
summer and hibernation experiments. Future researchers should consider testing only 
P. synxantha A and P. antarctica together in higher concentrations, specifically in a 
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Chapter 3: Field Application of Pseudomonas fluorescens Species Complex 
Bacteria onto Bat Boxes in the Greater Vancouver Area 
 
INTRODUCTION 
White-nose syndrome (WNS) is a fungal disease that can kill hibernating bats 
(Lorch et al. 2011; Frick et al. 2010). Mortality rates of up to 90-100% result from a 
cascade of physiological events and wing damage stemming from dehydration, 
electrolyte depletion, and starvation (Cryan et al. 2012; Turner at al. 2011; Verant et al. 
2014; Frick et al. 2015; Warnecke et al. 2013). White-nose syndrome is caused by the 
fungal pathogen Pseudogymnoascus destructans (Pd) and is touted as one of the most 
catastrophic wildlife diseases in recorded history (Drees et al. 2017; Frick et al. 2010; 
Frick et al. 2015; Leopardi et al. 2015). Three species are highly vulnerable to WNS, 
including Myotis lucifugus, Perimyotis subflavus, and M. septentrionalis, all listed as 
endangered in Canada (Committee on the Status of Endangered Wildlife in Canada, 
2013). The first infection occurred near New York Albany in 2006, presumably 
transferred from Eurasia (Blehert et al. 2009; Frick et al. 2010; Puechmaille et al. 2011a; 
Puechmaille et al. 2011b). Pd has been documented in seven Canadian provinces and 
39 American states and west of the Rockies Mountains, is found only in one state so 
far, Washington state (WNS 2019), although Pd has been detected in California. Pd is 
predicted to persist in cave hibernacula for up to a century after it is introduced due to 
its ability to act as a saprotroph and expand once introduced (Frick et al. 2017; Lindner 
et al. 2011; Lorch et al. 2013a; Lorch et al. 2013b; Reynolds and Barton 2014; Reynolds 
et al. 2015). Spores, when airborne, spread easily and are found on surfaces of infected 
bat hibernacula each hibernation cycle (Langwig et al. 2015a; Kokurewicz et al. 2016; 
Hoyt et al. 2019; Zhelyazkova et al. 2020). Bats returning to hibernation are rapidly re-
infected each year until the infection rate reaches near 100% after 2-3 years (Frick et 
al., 2017). However, this infection rate can be reduced if spore loads in the environment 
are kept low (Hoyt et al. 2020). Strategies to reduce growth of Pd on hibernating bats 




overall environmental loads and thus reduce population-level infection rate in a 
hibernaculum.   
Locations of bat hibernacula in the Pacific Northwest and Western North America 
are mostly unknown (Weller et al. 2018). This challenges most mitigation methods 
relying on knowledge of bat hibernacula (Fletcher et al. 2020; Weller et al. 2018). 
However, bat boxes used by maternity colonies present an alternative treatment site to 
roost hibernacula. Used annually by large numbers of adult females typically showing 
high fidelity to roosts (AK Department of Fish and Game 2021; www.batwatch.ca; 
www.bcbats.ca), maternity roosts are increasingly being identified by government 
outreach initiatives (e.g., AK Department of Fish and Game 2021) and community bat 
programs (e.g., www.batwatch.ca; www.bcbats.ca).Therefore a WNS mitigation method 
that targets maternity colonies could be highly impactful at a local population level to 
reducing mortality caused by WNS.   
With the goal of preventing Pd infection through application of a summer 
prophylaxis, rather than treating WNS in winter, we conducted a field trial on maternity 
colonies in the greater Vancouver area of Western Canada in August of 2019. Roosting 
substrates of maternity colonies were sprayed with a probiotic of anti-Pd bacteria (see 
Chapter 1) that were naturally sourced from wild bats wings. We selected four study 
sites, each with a large mixed colony of Myotis yumanensis and M. lucifugus. The 
roosts of two of these colonies were treated with probiotic, while there was no 
application of probiotic at the other two sites, leaving them as controls for comparison. 
Bats were studied at all four sites to establish baseline ecological and behavioural data 
and identify main roosts used during the pup-rearing season (June – August; Rensel 
2021).   
Bats and roosting substrates were inoculated with probiotic and then 
opportunistically swabbed for analysis of probiotic cell concentrations using quantitative 
PCR (qPCR). In order to track individual bats over time, including post-hibernation 
return (survival) rates, bats were tracked using Passive Integrated Transponder (PIT)-




(Rensel 2021). Although we performed the pilot probiotic application late in the season, 
we still managed to compare treatment bats to controls in their separate locations prior 
to bats leaving for hibernation.  
The probiotic cocktail we developed and field test here is comprised of 4 anti-Pd 
bacteria species belonging to the Pseudomonas fluorescens species complex: P. 
azotoformans, P. antarctica, and two strains of P. synxantha. These bacteria 
demonstrated inhibition of Pd growth in vitro and were isolated from Eptesicus fuscus, 
M. yumanensis, Corynorhinus townsendii, and M. evotis. Many species of bacteria 
within the P. fluorescens species complex are known for secreting antimicrobial 
secondary metabolites, and numerous studies have now shown that several strains of 
bacteria from the P. fluorescens species complex inhibit Pd growth both in vitro and in 
vivo in lab settings (Cheng et al. 2016; Lemieux-Labonté et al., 2017; Hoyt et al. 2015) 
and recently in a controlled hibernation field trial (Hoyt et al. 2019). Hoyt et al. (2019) 
demonstrated that certain bacteria from the P. fluorescens species complex reduce the 
mortality rate of WNS. Here I describe the first study of bacteria from the Pseudomonas 
fluorescens species complex to be used as a prophylaxis and applied at maternity 
roosts, in advance of hibernation. We used autoclaved clay powder mixed with freeze-
dried probiotic to dilute the probiotic and distribute it within bat boxes. Clay is inert and 
resembles similar substrates found in natural crevice roosts used by bats such as rock 
crevices. The premise of our approach is that bats coat their wings and bodies with 
probiotic clay as they roost against the inoculated surfaces of their bat box or building 
roosts. My objectives were to inoculate maternity roost substrates with the four-strain 
probiotic cocktail, targeting human-built structures in summer, and subsequently monitor 
the presence, concentration and viability of probiotic bacteria on treated roosting 
substrates and wings of bats that have roosted on these substrates. Additionally, I 
aimed to examine longevity of persistence on roosting surfaces and wings between 
seasons, and monitor return rates (survival) of bats post-hibernation following exposure 
to the probiotic cocktail. To date, I have been able to test roosting surfaces, but due to 
COVID-19 field restrictions, no swab-sampling of bat wings has occurred. Additionally, 








Applicator design and probiotic preparation 
Four different species of bacteria were included in the probiotic mixture: 
Pseudomonas azotoformans isolated from a C. townsendii, P. synxantha A isolated 
from a M. yumanensis, P. antarctica isolated from a M. evotis, and P. synxantha B 
isolated from a E. fuscus. These bacterial species inhibit the growth of Pd and are a mix 
of partial and full inhibitors (see Chapter 2). Bacteria were individually grown in 100mLof 
lysogeny broth (LB) and incubated at 30oC, shaking at ~150rpm over night. Culture’s 
were then centrifuged at 5000 rpm for 10 min and rinsed with Phosphate Buffer Saline 
(PBS) three times. The cells were mixed with 1g of sterile clay powder and freeze-dried 
in a cryo-lyophilizer for a minimum of 2 hours. Viability and bacteria counts were tested 
by diluting and spread-plating and serial diluting 0.01g of freeze-dried suspension onto 
LB agar , incubating at 25oC for 24hrs and counting the Colony Forming Units (CFU) the 
next day. The synxantha A species final yield was 2.54x109 cells per gram of freeze-
dried suspension, the P. synxantha B species final yield was 1.02x1012 cells per gram of 
freeze-dried suspension, the P. antarctica species was 9.82x1010 cells per gram of 
freeze-dried suspension, and the P. azotoformans species final yield was 6.64x1011 
cells per gram of freeze-dried suspension. Each dosage was composed of 250 million 
cells of each species that was mixed with 30g of clay for treatment of an individual bat 
box chamber. Clay was added and vortexed on medium speed for 20 seconds in small 
increments of 5g to promote homogeneity in each dosage. The final product was 40 
doses of probiotic containing 1 billion freeze-dried probiotic per dose per bat box 
chamber.  
The probiotic-containing clay powder then needed to be propelled up into the bat 
box chambers. I devised a propellant technique using a can of emzone compressed air 




hole into each end of the centrifuge tube; using a silicone seal, I attached the thin 
1.5mm diameter tube that is supplied with the compressed air can to one end of the 
centrifuge tube, and a large 10mm diameter rubber straw to the other end which was 
the centrifuge tube’s lid. The rubber straw was 30cm long and flexible for directing the 
spray up into each chamber of the bat box. I loaded the probiotic-clay powder into the 
centrifuge tube by opening and closing the screw cap lid that was now attached to the 
rubber straw. During deployment, powdered clay placed in the tube was propelled out of 
the straw into each chamber of the bat box by depressing the nozzle of the spray can. A 
light mist of water (~50ml of sterile de-ionized water per bat box chamber) was sprayed 
into the box using a manual pump garden wand sprayer (with a misting wand with a 
nozzle small enough in diameter to reach into each chamber) beforehand to enable the 
propelled powder to adhere to the wood and assisted with activating the freeze-dried 
bacteria. In subsequent field deployments, we substituted a manual action tire pump in 
place of the aerosol spray can. This reduces cost and is quicker, because the aerosol 
air cans can become very cold, requiring a resting period before continuing to spray, 
and they are non-refillable.    
Field Application 
In 2018 and 2019, 464 bats were individually marked with either PIT-tags (Biomark, ID, 
USA; 8 mm) or metal arm bands (Porzana, UK; 2.4 or 2.7 mm diameter, split-ring 
lipped). Bats were captured and marked at three study sites in the lower mainland of 
British Columbia (Figure 3.1): 220 bats were banded at Colony Farm Regional Park, 
213 bats were banded and 493 were PIT-tagged at Stave Lake BC Hydro (of which 15 
received both PIT-tags and bands), and 235 bats were banded and 337 were PIT-
tagged at Alice Lake Provincial Park (of which16 bats received both PIT-tags and 
bands. Each band and/or PIT tag enabled individual identification of bats in subsequent 
monitoring. PIT tagged bats, when entering/exiting a roost equipped with a PIT tag 
reader of probiotic levels and diversification of controls vs treatment.  
Probiotic was applied to roosting surfaces at two study locations: Colony Farm 




main bat boxes used by bats at Colony Farm park (numbered 1-4 from left to right of the 
park). I used a standard dose one billion cells (250 million cells of each of the four 
probiotic species) per chamber: each bat box had 7 chambers, for a total of 28 doses of 
probiotic-clay deployed at this site. Three bat boxes were sprayed at night when bats 
left to forage and one bat box was sprayed during daylight hours when no bats were 
present.  
At Stave Lake BC Hydro, probiotic-clay powder was sprayed into each chamber 
of three four–chambered bat boxes, and on the outside of the roost entrance to a 
building (Stave Lodge) on August 8th, 2019. Bats were not present in the bat boxes 
during the day when probiotic was applied, but were present inside the lodge roost.  
 
Figure 3.1. Map of field study sites in the Greater Vancouver region in southwestern 
British Columbia. Treatment sites were Colony Farm Regional Park and Stave Lake BC 
Hydro. Control location was Alice Lake. Each location has multiple roosts used by a mix 




Roost Substrate and Wing Swab Samples 
To track the presence of each probiotic bacteria, bats’ wings were swabbed with 
a sterile polyester swab is lightly dragged along the edge of both bat’s arm bones on the 
dorsal surface (Appendix H). Each polyester swab tip was stored in a sterile Eppendorf 
tube, and kept frozen prior to processing. Swabs were washed with 0.5ml PBS solution 
and vortexed to dislodge cells picked up in the swab. The PBS suspension was then 
sonicated in a sonicating water bath for 30 seconds in a sterile glass vial. Similarly, for 
swab sampling of roost substrates, a polyester swab with a long handle was dragged 
across a roost surface along a predetermined line or within a predetermined area. 
Swabbing occurred at the entrances of each inoculated bat box chamber and the boiler 
room entrance. Swabbing areas were kept consistent between bats and between roost 
surfaces; therefore the measured starting quantities are only comparable relative to 
their own groups. Bat swabs were divided based on mean wing area seen in the captive 
trial of 19.7cm due to measurement of field trial bats not taken at the time. The boiler 
room entrance and bat box swabs were not measured for swabbing area.  
Baseline and control swabs of bats were taken before the bat box probiotic 
inoculations. Adult females from each site were swab-sampled for baseline 
concentrations of naturally-occurring bacteria matching the probiotic strains constituting 
the probiotic cocktail: one M. yumanensis/lucifugus bat  from Colony Farm on July 11th; 
one M. yumanensis/lucifugus bat from Stave Lake on July 29th. An individual M. 
yumanensis/lucifugus bat was swabbed from Alice Lake on July 24th, July 31st, and 
August 14th as a control. This latter sample from the Control site was one week after 
application of the probiotic at the treatment sites. All samples were qPCR-analyzed with 
the custom probes for 3 of the 4 bacteria making up the probiotic. These baseline levels 
formed the zero baseline when measuring the starting quantity of the treatment bat 
swabs.  
Treatment of bat boxes occurred on August 7th for Colony Farms and August 8th 
for Stave Lake. There were three bat boxes in total at Stave Lake, two of which 




“Hayward Bat Box”. Four bat boxes were inoculated at Colony Farms. Bat boxes were 
monitored manually and through PIT tag readers for bat activity in the following weeks 
after probiotic inoculation. Bats were not seen roosting in any bat boxes at Colony 
Farms when inspected on August 13th and a lack of a PIT tag reader at this site 
precluded knowing if bats were present on other days. An adult female M. lucifugus and 
a juvenile female M. yumanensis/lucifugus species were captured in the Colony Farm 
site using mist nets and swabbed for qPCR analysis of the probiotic species. It could not 
be confirmed that they had been using the probiotic-inoculated bat box roosts. There 
were no bats detected in roost boxes from Colony Farms throughout the rest of the trial, 
and this was unsurprising given that this colony leaves these roosts by mid-August each 
year (J. Saremba, Burke Mountain Naturalists, pers. comm.).  
Each chamber of the three inoculated bat boxes and the boiler room roost 
entrance were swabbed on August 22nd, 14 days following application. Swabs were 
attached to a wood dowel and rubbed against a pre-determined and consistent bat box 
surface area vertically in each chamber. Relative quantity of each of the probiotic 
bacteria in each swab was measured using qPCR. On August 27th, 19 days after 
probiotic application at roosts, 33 bats were swabbed at the Stave Lake study site. Bats 
were captured using a harp trap from the Hayward Lake bat box.  
On March 3rd, 2020, overwinter survivability of the probiotic species was tested 
by swab-sampling previously inoculated roosting surfaces. We sampled bat boxes 1-4 
from Colony Farms three times (n=12 swabs), 2 swabs were frozen in water and the 
third swab was placed in broth and allowed to grow in an incubator for 12 hours before 
being frozen. Box 1 from Stave Lake was sampled three times (n=3), 2 swabs were 
frozen in water and the third swab was placed in broth and allowed to grow in an 
incubator for 12 hours before being frozen.  
qPCR Analysis 
All swab samples were processed using a relative-quantity multiplex probe-




2000) were used to quantify cell concentrations in swabs for each probiotic isolate. We 
designed strain-specific qPCR probes, with a 5’ fluorophore tag and 3’ quencher, for 
use in multiplex reaction, measuring the relative combination of 3 of the 4 probiotic 
species in each reaction. Species measured with qPCR were P. azotoformans, P. 
synxantha A and B. Standards were created through serial dilution of cells suspension 
(105, 104, 103, and 102) from each probiotic strain and all reactions were carried out in 
triplicate. We then created a standard curve using the Cycle Threshold (Cq) values from 
cell standards of known concentration. Fitting the Cq values from samples of unknown 
concentration enable extrapolation of the number of cells present in each swab. 
Standard error is presented for all means. 
RESULTS 
Summer Swab Samples – Bats and Roosts 
Three strains of the probiotic bacteria were detected on both bats from Colony 
Farms, with P. synxantha strain A 18.7-36.2 times higher in concentration than the other 
two bacteria when both swab concentrations are combined. P. synxantha strain A 
concentration was 2.36 ± .602 x103 cells/cm2 (1.28 - 3.36 x103, n= 3 replicates) on a 
juvenile and 3.87 ± 3.18x104 cells/cm2 (5.47 - 102 x103, n= 3 replicates) and on an adult 
female; P. synxantha strain B was 136 ± 36.0 cells/cm2 (70.6-195, n= 3 replicates) and 
2.06 ± 1.67 x103 cells/cm2 (295-5429, n= 3 replicates); P. azotoformans was 67.8 ± 18 
cells/cm2 (37.1-99.3, n=3 replicates) and 1.06 ± .865 x103 cells/cm2 (.153-2.79 x103, 
n=3 explicates), respectively. Unfortunately due to problems with the 4th PCR probe, 
presence of P. antarctica could not be tested. High variance between replicates likely 
reflects variability occurring from sampling during qPCR.  
Three bat boxes (Lodge Bat Box #1, Lodge Bat Box #2, and Hayward Lake Box) 
and the boiler room roost entrance Stave Lodge were swabbed at Stave Lake BC Hydro 
on August 22nd for detection of probiotic 22 days after the roosts were first inoculated. 
All but one of the Lodge boxes had detectable amounts of probiotic bacteria within each 
chamber; Lodge Bat Box 1 inexplicably had no detectable amount of probiotic in any of 




bacteria (10-12.5 times more; Figures 3.2 and 3.3) within each chamber of both bat 
boxes and at the boiler room roost entrance (Figure 3.4). Lodge Bat Box 2 and 3 each 
varied in the amount of probiotic among chambers; the former had the greatest 
abundance of probiotic bacteria within its third chamber, followed by the first, fourth, and 
second and each probiotic bacteria species was detected in measurable quantities. 
Hayward Bat Box had a greater number of probiotic bacteria present within each 
chamber compared to Lodge Bat Box 2. These results might reflect the randomness of 
the application process given that not all clay powder sticks when sprayed into the bat 
box chambers, and the spraying consistency across the substrate is largely uncontrolled 
which means that depending on where the swab sample is taken, probiotic 
concentrations can vary widely. Interestingly, bacteria in Hayward Bat Box was detected 
highest in the outer chamber 4, and progressively less bacteria found in each chamber, 
with chamber 1 having the least  (Figure 3.3). Bats typically roost in chamber 1 as that 
chamber is the first one they enter from the landing platform. Bats can move 
progressively from one chamber to the next moving outward, and therefore all bats will 
pass through chamber 1, each picking up probiotic clay, and depending on the number 
of bats in the box, they may not proceed past chamber 1.   
At the entrance of the boiler room roost entrance, two swabs were taken (Figure 
3.4) and each had a detectable number of bacteria:  P. synxantha A had a marginally 
greater number of cells compared to P. synxantha B and P. azotoformans.  
At the control site, Alice Lake Provincial Park, 3 bats were captured (one per 
night on 24 July, 31 July and 14 August, 2019). No detectable probiotic bacteria were 
found on their wings through qPCR analysis. The two baseline swabs from each bat at 





Figure 3.2. qPCR probiotic data comparison of P. azotoformans, and strains A and B of 
P. synxantha from 4 swabbed chambers of Bat Box 2 from Stave Lake on August 22nd. 



















































Figure 3.3. qPCR probiotic data comparison of P. azotoformans, and P. synxantha A 
and B from each of four swab-sampled chambers of Hayward Bat Box from Stave Lake 
on August 22nd. A. shows linear scale and the notable magnitude of difference in cell 
concentrations, with >10x greater P. synxantha A strain. B. Same data plotted on 




















































Figure 3.4. qPCR probiotic data of P. azotoformans, and strains A and B of P. 
synxantha from 2 swabs of the boiler room entrance at Stave Lake on August 22nd, 
2019. Note the logarithmic scale. 
PIT tag readers at probiotic-treated Stave Lake roost sites confirmed that bats 
used all 3 bat boxes as a night roost for at least 5 days after inoculation with probiotic. 
The boiler room roost was consistently occupied. At Hayward Bat Box, 33 bats were 
captured with harp traps and swab-sampled on August 27th, almost three weeks since 
the roosting chambers were inoculated on August 8th. The majority of swabbed bats 
were adult female M. lucifugus, except for one juvenile female and one adult M. 
yumanensis (Table 3.1). Ten of the 33 samples (30%) had detectable amounts of 
probiotic on their wings.  
Of the 10 bats with a quantifiable number of probiotic bacteria on their wings, 
bacterial strains and concentrations varied widely. P. synxantha strain B was the most 
widespread (8 of 10 swabs) and its starting quantities were higher than P. azotoformans 
in samples where both bacteria were found; however, the most abundant probiotic 
bacteria was clearly P. synxantha strain A (5 of 10 swabs; Figure 3.5). P. azotoformans 

















Boiler Room Entrance Swab





Figure 3.5. Quantitative PCR analysis of wings of 10 captured bats (for which probiotic 
was detected) on August 27th, 2019 at Stave Lake study site. Presence of three 
probiotic bacteria were tested:  P. azotoformans, and strains A and B of P. synxantha. 





















































replicates Age Sex Species 
1 P. synxantha B 2 A F MYLU 
1 P. synxantha A 1 A F MYLU 
1 P. azotoformans 1 A F MYLU 
2 P. synxantha B 1 J F MYLU 
2 P. synxantha A  J F MYLU 
2 P. azotoformans  J F MYLU 
3 P. synxantha B 1 A F MYLU 
3 P. synxantha A  A F MYLU 
3 P. azotoformans  A F MYLU 
4 P. synxantha B 1 A F MYLU 
4 P. synxantha A 1 A F MYLU 
4 P. azotoformans 1 A F MYLU 
5 P. synxantha B 1 A F YULU 
5 P. synxantha A  A F YULU 
5 P. azotoformans  A F YULU 
6 P. synxantha B  A F MYLU 
6 P. synxantha A 3 A F MYLU 
6 P. azotoformans  A F MYLU 
7 P. synxantha B 1 A F MYLU 
7 P. synxantha A  A F MYLU 
7 P. azotoformans  A F MYLU 
8 P. synxantha B  A F MYLU 
8 P. synxantha A 1 A F MYLU 
8 P. azotoformans  A F MYLU 
9 P. synxantha B 1 A F MYLU 
9 P. synxantha A 1 A F MYLU 
9 P. azotoformans 1 A F MYLU 
10 P. synxantha B 1 A F MYLU 
10 P. synxantha A  A F MYLU 
10 P. azotoformans  A F MYLU 
11 P. synxantha B  J M MYLU 
11 P. synxantha A 1 J M MYLU 
11 P. azotoformans  J M MYLU 





Spring Swab Samples of Roosts 
P. azotoformans, P. synxantha A, and P. synxantha B were not present in any of 
the swabs of roost substrates in March 2020. Broth was inoculated with swab 
suspension as a way to try to grow any trace probiotic cells, however and only one 
swab from a bat box at Colony Farm (Bat Box 2) grew one of the strains -- P. synxantha 
A, however it was not present in the water sample.   
DISCUSSION 
We determined that probiotic could be transferred to wild free-flying bats by 
applying it to their roost substrates. We found evidence at both of our treatment sites, 
that bats had probiotic bacteria on their wings several weeks after roost inoculation. At 
Colony Farm, only 2 bats were captured, and they had both detectable amounts of 
probiotic on their wings one week after bat box inoculation. Inoculated bat boxes from 
Colony Farm were empty after inoculation throughout the rest of the trial, which is 
consistent with their annual pattern of leaving the bat box array by mid-August each 
year (John Saremba, Burke Mountain Naturalists, unpublished data). These bats may 
leave the area for mating and hibernation, and this colony may leave earlier than others 
if they have a long ways to travel to hibernacula (Norquay et al. 2013), or they have 
more suitable roosts for late summer/early fall). Bats were still present at Stave Lake at 
least three weeks after inoculation of the three bat boxes and the boiler room roost 
entrance. Three of the 4 probiotic species were detected at two of the three bat box 
roosts and at the Lodge roost entrance at Stave Lake, several weeks following roost 
inoculation. It was not possible to test for the presence of the fourth bacteria species, P. 
antarctica because the PCR probe did not anneal properly during qPCR DNA 
amplification. The other 3 probiotic species were present in abundant numbers with P. 
synxantha A being greater than the others by 17.1-43.9 fold in Bat Box 2, 15.9-44.7 fold 
in Hayward Bat Box, and 15.9-47.8 fold at the boiler room roost entrance. Although the 
protocol used to create the probiotic-clay and the application of the clay into each 
roosting chamber was designed to apply each probiotic bacteria in approximately equal 




wing substrates. The reason is unknown, but may due to its ability to proliferate in the 
warm bat roost conditions. This same uneven proliferation was not seen in hibernation 
conditions (see Chapter 2). What has not been confirmed is whether the bacterial cells 
of all probiotic cells swabbed from bats and roosts are viable or whether the DNA of 
nonviable cells remains and is being amplified. For example, if P. synxantha B and P. 
azotoformans are not viable and only DNA remains to be amplified, but P. azotoformans 
is viable, then it would appear that this latter strain has drastically outnumbered the 
other strains when in fact its cell division is just indicative of viability. This strain, 
however, might truly be more prolific in the warm summer roosts conditions and on 
warm-bodied bats (adult females raising young maintain warm bodies, e.g., Lausen and 
Barclay 2003). Further experimentation and sampling will need to be done to shed light 
on viability in relation to relative concentrations of the four probiotic bacteria. We had 
planned for our broth inoculations of each sample to test for viability, but this proved to 
be unreliable; this may stem from an underestimate of the time needed for cell division, 
or from competition of other microbes in a rich nutrient environment.  
We know from our captive bat trials that probiotic remains on bat box substrates 
for several months after application in summer months (see Chapter 2). However, this 
was the first test of whether the probiotic would still be detectable on bat box roosting 
substrates the following spring. We detected none of the probiotic species in the 
overwinter subsampling of bat boxes at Stave Lake in March. Only one sample of one 
chamber in one box at Colony Farm showed a trace quantity of P. synxantha A from a 
broth sample. This failure to find probiotic cells on the roosting surfaces suggests 
significant die off of the probiotic in the bat boxes overwinter. However the presence of 
P. synxantha A in one broth sample may suggest a small quantity of cells were able to 
grow when exposed to broth, but were too small to be quantified in water. Application 
protocol, frequency, and/or cell concentrations should be adjusted in future field 
activities to verify conclusions and determine a potential cause for the overwintering die-
off; for example, freezing temperatures might be responsible for no detection of cells in 
the broth, but the fact that the water samples also proved to have no bacterial DNA to 




enzymatic breakdown of the probiotic cells by other microbes on the roosting surface. 
Application and sampling of a roost substrate in a heated building will help to determine 
if temperature is a factor, or whether there other potential causes like microbial 
competition. In this study we did not swab at any other time points between winter and 
spring, therefore we do not know the exact time frame in which the probiotic species 
were present. Multiple sampling periods and environmental condition analysis, such as 
temperature and humidity, throughout winter could provide better insight to each 
bacteria species survivability. 
Bat boxes were not swabbed at Colony Farm due to no bats being observed 
within the bat boxes after the first and second week after inoculation. Unlike at Stave 
and Alice Lake sites, bats at this site were not PIT-tagged, and so presence of bats 
could not be known unless visually observed. This together with the fact that this colony 
is known to leave these bat boxes annually in early to mid August, resulted in few bats 
being sampled.   
Bat hibernacula in western United States is largely unknown, with 95% of counts 
containing less than or equal to 10 myotis species in each roost (Weller et al., 2018). At 
this time it is impossible to apply probiotic to hibernating sites, and even then, they 
would likely be heavily disturbed. Future methods should consider a quicker, and more 
efficient method of application that would only be conducted with 1 or 2 people.  
Our results found that 30% of swabbed bats from Stave Lake had a detectable 
amount of applied probiotic on their wings. All bats found with our probiotic on their 
wings were female MYLU species. The period between bat box inoculation and bat 
swabbing was 19 days from August 8th until August 27th. This would presume that 
swabbed bats likely came into direct contact with the inoculated probiotic within the bat 
boxes. To further re-iterate our findings, we saw none of our probiotic species in the 
baseline wild bat swabs from the Stave Lake bat swab, the Colony farms bat swab, and 
the 2 bat swabs from Alice Lake from July and early August. Like in the bat box 
chambers, P. synxantha A was much more abundant on each bat swab compared to 




present on their wings with the dosage we used. Although an estimated 250 million cells 
of each anti-Pd bacteria species were inoculated onto each bat box, our highest result 
was 2.37 ± .237 x104 (.190 - 2.64 x104) cells of synxantha  A as seen in chamber 4 of 
the Hayward Bat Box. The highest result seen on bats was 1.11x103 ± 0 cells/cm2 of P. 
synxantha A that used the Hayward Bat Box. Interestingly, the 2 most highly used 
chambers of the Hayward box (chambers 1 and 2 near the landing platform entrance) 
were noticeably lower in quantity of all microbes compared to the least used chambers 
(3 and 4;Figure 3.3). This may reflect the overall use of the bat box by bats and the 
adhering of cells to bat skin and fur that is expected to occur. The bats caught at Colony 
Farms had a much higher result of 3.87 ± 3.18 x104 (8.38 - 102 x103)  P. synxantha 
cells/cm2, however, we do not have bat box swabs to compare to. A larger abundance 
of bacteria on bats and within bat boxes may stimulate biofilm growth. Ideally, we would 
like to see biofilm formation within the bat box and eventually hibernacula from bats 
transferring it. Biofilm could form and survive in bat hibernacula because of its above 
freezing, humid and stable refrigerator-like temperatures (Fenton and Robert 1980; 
Gennari and Dragotto 1992). Therefore spore loads within the environment and on 
individual bats would likely be lower from the anti-Pd metabolites released from the 
biofilm. 
For further studies we would recommend using repeated, and possibly higher, 
dosages of anti-Pd bacteria from the P. fluorescens species complex and further 
monitoring of the bat box chambers throughout winter and into spring. Consideration of 
repeated dosing of bat boxes is warranted because of the high concentrations of 
probiotic bacteria seen in the captive trial hibernation experiment (chapter 2). The 
captive bats from the hibernation trial in chapter 2 used a bat box that was doused twice 
with probiotic on September 30th and October 7th before moving into the hibernation trial 
on November 7th. Probiotic concentrations greatly increased throughout the hibernation 
trial into the hundreds of thousands per cm2. Wild bats may have a greater 
concentration of detectable probiotic on their wings if the bat boxes were inoculated 
multiple times, similar to our captive trial. Clay has previously been documented as a 




repeated dosages of anti-Pd bacteria to maintain bacteria proliferation and growth has 
been recommended by other researchers when using anti-Pd bacteria to reduce WNS 
impacts (Hoyt et al. 2019). Utilizing P. synxantha A, P. azotoformans and P. synxantha 
B colonization could be a useful management practice when hibernacula are not known. 
These results give an insight into new types of management practices that rely on 
natural anti-Pd probiotics found on a smaller percentage of wild bats and spreading it 
throughout bat species populations.  
In conclusion, we inoculated bat boxes and a building roost with our anti-Pd 
probiotic naturally found on wild bats, and later detect the same probiotic species on 
bats that were using the bat boxes. Inoculating the roost substrate directly would have 
likely been a better choice than the roost entrance of the building, as not all bats likely 
encountered the probiotic. Probiotic species were not detectable in the same bat boxes 
following exposure to winter conditions and seem to have died off by spring. Further 
research is needed to examine different dosage concentrations and treatment 
frequency needed to sustain probiotic cell numbers both on roost surfaces, and bat 
wings throughout the entire hibernation period into spring. Monitoring cell 
concentrations on bat species while they hibernate in the wild would be ideal, however, 
this may be impossible due to bat hibernacula being mostly unknown. Instead, sampling 
efforts should be bolstered to increase sampling size and frequency throughout the fall 
season to create a timeline of probiotic abundance on bats and bat boxes. Methods 
should also be implemented to determine viability and metabolite abundance of 
probiotic bacteria on the bat box and bats throughout fall and into winter if possible. This 
study is one step towards alleviating the selective pressure that western WNS impacted 
species are facing during hibernation. In the future, affected bats may survive 
hibernation and Pd exposure if they were to maintain anti-Pd bacteria numbers and 
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Chapter 4: Inoculation and Quantification of Pseudomonas fluorescens Species 
Complex Bacteria and Pseudogymnoascus destructans on Myotis Patagia 
 
INTRODUCTION 
White-nose syndrome (WNS) is a deadly infectious disease that results in bat 
mortality during hibernation (Frick et al. 2010). This disease is caused by the fungal 
pathogen Pseudogymnoascus destructans (Pd) which has caused millions of bat deaths 
across eastern North America (Frick et al. 2010; USFWS 2012). Surviving bats will 
groom off the fungus and persist, though survival rates for some populations have been 
less than 10%; , Pd fungus can persist in caves and infect bats in each subsequent 
hibernation period (Frick et al. 2015; Lorch et al. 2011; Hoyt et al. 2015). Pd is a 
psychrophilic fungus and grows optimally between 12.5-15.8oC in the presence of high 
relative humidity (80.5%; Verant et al. 2012; Marroquin et al. 2017). These temperature 
and humidity conditions are found in caves in which many bats choose to hibernate 
(Davis 1970; Fenton 1970; Anderson and Robert 1971; Raesly and Gates 1987; Cryan 
et al. 2010; Vanderwolf et al. 2012; Kurta 2014). White-nose syndrome was introduced 
into North America in 2006 and bat mortalities were first noted in 2007 near Albany, 
New York (Blehert et al. 2009; Frick et al. 2010). Today it now resides in 39 states and 
seven Canadian provinces (USFWS 2020). Bats are thought to fill crucial roles in 
ecosystems, agriculture, and forests (Boyles et al. 2011; Kunz et al. 2011). They are 
voracious predators of insect pests and provide a natural method of insect control 
without the use of pesticides. Vector-borne diseases that utilize insects as a method of 
transmission may in part managed be by insectivorous bats. Natural pest control 
services of bats there is estimated to be worth billions of dollars to the US agricultural 
industry (Boyles et al. 2011; Kunz et al. 2011).Therefore it is especially important to 
understand how to control WNS infection in bats to prevent or reduce further mortalities. 
This is especially important as the disease spreads in western North America where the 
species diversity of bats far exceeds that of the eastern part of the continent. In British 
Columbia (B.C.) in particular, bats represent nearly 20% of small mammal diversity 




species in B.C. are known to hibernate (Naughton 2012), suggesting that WNS could 
substantially decrease mammal diversity in the province (and in Canada). With a 
growing understanding of the importance of biodiversity to the function and health of 
ecosystems (e.g., Battista et al. 2016), control over this invasive bat fungus takes on 
even greater urgency as it infects new western bat species for which susceptibility is as 
of yet unknown. 
White-nose syndrome fungal infection is subtle to detect in bat wings and deadly 
during hibernation (Meteyer et al. 2009). Signs of infection are inconsistent but typically 
include rough patches on the face, ears, forearms, wing membranes, and feet. Skin 
tissues may show irregular pigmentation or small tears in wing membranes from Pd 
infection. The wing membrane epidermis is composed of 2 single cell layers that are 
separated by a thin layer of blood and lymphatic vessels, nerves, muscles and 
specialized connective tissues (Makanya et al. 2007). Pd has shown to highly express 
94 genes during the cutaneous infection of M. lucifugus, and 34 genes that directly 
contribute to its virulence (Reeder at al. 2017). These genes include expression of 
enzymes lipase 1 and squalene monooxygenase which degrade surface lipids and 
sebum found on the bat wing epidermis. Other genes significantly improved Pd’s heat 
shock response, cell wall remodelling and micronutrient acquisition to likely evade host 
pattern recognition receptors and antibody responses. Pseudogymnoascus destructans 
will commonly produce cup like erosions that are filled with fungal hyphae on bat wing 
membranes and ulcerate the underlying connective tissue as infection continues. 
Pseudogymnoascus destructans  hyphae are septate and will branch in either uniform, 
parallel walls, or irregular bulging walls that are larger in diameter (Makanya et al 2007; 
Meteyer et al. 2009). Hyphae will destroy apocrine glands, hair follicles and sebaceous 
glands, and replace host connective tissue, blood and lymphatic vessels, glandular 
structures, elastin and muscle fibers with Pd digests.  
Ulceration and invasion of Pd into host tissue can cause many physiological 
complications for its host. Damage to the epidermis has been shown to cause eventual 




hibernation (Verant et al. 2014; Warneke et al. 2013). Pseudogymnoascus destructans  
hyphae will damage underlying connective tissue and increase vascular permeability, 
which further accelerates fluid loss and can cause hypovolaemia which would trigger 
bats to awake from torpor and drink water (Warnecke et al. 2013). Furthermore, 
destruction of epidermis can prevent normal blood flow and proper CO2 expiration, 
increasing ventilation rates and possibly hyperventilation, which further contributes to 
arousal frequency and evaporative water loss (EWL; Verant et al. 2014; Warnecke et al. 
2013). Sodium and chloride levels will drastically decrease due to hibernacula not 
containing sufficient electrolytes (eg. insects) to replenish losses caused by the disease 
(Cryan et al. 2013). Imbalance of electrolyte levels can interfere with homeostatic 
function and lead to possible impaired neural and/or heart function as seen in other 
mammals. It has been proven that bats exhibit heightened energy expenditure and EWL 
after infection during torpor and this directly contributes to WNS pathophysiology 
(McGuire et al. 2017). Bats will initially express a heightened torpor metabolic rate 
(TMR) and this is possibly due to a small immune response when bats initially try to 
fight off the infection (Field et al. 2015, Lilley et al. 2017). However, torpor will typically 
suppress a bat’s immune system making them more vulnerable to infection as 
hibernation continues (Bouma et al., 2010; Geiser 2004; Moore et al., 2011). Put simply, 
bat mortality is the result of premature arousal from torpor because of physiological 
imbalances and results in depletion of energy reserves for winter survival (Storm and 
Boyles 2010; Cryan et al. 2013; Warneke et al. 2013; Verant et al. 2014).  
Methods of controlling Pd infection in wild bats are being researched, but more 
than a decade after the disease’s discovery in North America, field-ready preventative 
or treatment tools do not yet exist. Anti-fungal agents such as fungicidal drugs that are 
commonly used in agriculture, vaccines, and UV light are being studied (Palmer et al. 
2018; Rocke et al. 2019.). Fungicidal drugs were among the first treatment methods 
tested and proven to be unsuccessful. Not only can anti-fungal drugs be dangerous to a 
bat’s natural microbiome and expensive, but they can be toxic and have effects on non-
target taxa when deployed in bat roosts. Vaccines are expensive, require extensive 




and does not reach under bats arms when they hibernate, leaving reservoirs for the 
fungus to persist. Utilizing anti-Pd bacteria has been a promising method of controlling 
Pd infection and an increasingly interesting form of controlling WNS infection. In vitro 
tests utilizing antifungal metabolites from bacteria can limit growth of Pd mycelia and 
spores (Cheng et al. 2016; Chaturvedi et al. 2011; Cornelison et al. 2014a; Cornelison 
et al. 2014b; Lemieux-Labonté et al., 2017; Micalizzi and Smith 2020; Hoyt et al. 2015). 
Researchers from University of California have developed an in vivo screening method 
using explant chambers to examine Pd infected bat tissue in the presence of R. 
rhodochrous (strain DAP 96253 induced with urea; Cornelison et al. 2014b). In vivo 
tests prevent other fast growing fungal microbes and mold from interfering with Pd and 
anti-Pd bacterial inoculation.  
Here, I assess whether severed Myotis yumanensis bat wings treated with a 
cocktail of anti-Pd Pseudomonas bacteria can prevent or slow Pd spore germination 
and/or hyphae growth. The anti-Pd cocktail contains four synergistic bacterial strains 
from Western Canada that were originally found on wild bat wings and inhibit the growth 
of Pd (see Chapter 2). Here I investigate whether the probiotic reduces Pd growth or 
germination. I used two different approaches to testing this: one using wings of bats 
who had been indirectly inoculated via application of a probiotic-clay powder (see 
Chapter 2) on their roosting surfaces; the other using direct inoculation of live wing skin 
excised from a freshly euthanized bat. Here I present results of Pd-challenge 
experiments. where I exposed captive bats to the probiotic at their bat box roosts, 
humanely euthanized the bats,  severed their wings, and challenged them with Pd to 
quantify and describe subsequent Pd spore germination or Pd hyphae growth time. I 
also performed an experiment using wings of wild bats that were not exposed to 
probiotic, whereby the skin tissue is kept partially alive using tissue media in custom 
explant chambers. Probiotic cells and Pd spores are applied to the explants and the 
subsequent germination is examined and compared between explants with and without 








The first Pd challenge experiment used two synergistic bacterial strains of 
Pseudomonas. Both were isolated from an adult female Eptesicus fuscus caught in a 
mine outside of Salmo in the Kootenay area of British Columbia. Only one of these were 
carried through to the next probiotic cocktail and it is now identified as P. synxantha B. 
The present anti-Pd cocktail contains four synergistic bacterial strains from 
western Canada: Pseudomonas synxantha strains A and B, P. azotoformans, and P. 
antarctica. Each isolate was previously sourced from bats in BC. Pseudomonas 
synxantha strain A was isolated from a M. yumanensis at a mine hibernaculum near 
Salmo, BC; strain B was isolated from an adult female E. fuscus captured free-flying at 
a mine near Salmo, BC (as told above); P. azotoformans was isolated from a 
Corynorhinus townsendii adult bat caught at a maternity roost in Deroche, BC; and P. 
antarctica was sourced from a female juvenile M. evotis at from a mine hibernaculum 
near Nelway, BC. 
 
Pd Challenge - Ex vivo wing culture 
After application of the probiotic cocktail to captive bats indirectly via treatment of 
their roosting surfaces (see Chapter 2), wings of euthanized bats were challenged with 
Pd to investigate growth of Pd on these previously inoculated wings versus wings of 
bats that had not roosted on an inoculated roosting surface.  
In all experiments, bats were humanely euthanized and separated into control 
(no probiotic) and treatment (probiotic) groups for fungal Pd inoculation. Each wing was 
inoculated with fungal Pd spores as described below. Reduced Pd growth on treatment 
group wings compared to control group wings would suggest previously applied 
probiotic was inhibiting Pd growth. 
In Experiment A, after removal from the carcasses, the wings were immediately 




bioassay plate (n=12 wings). Two petri dishes were filled with water to generate high 
humidity and the bioassay plates were placed into a 15oC incubator to simulate wild Pd 
growth conditions. Six wings were used from our trial for testing Pd inoculation. Three 
‘types’ of wings were used: wings of control bats, and wings from two types of treatment 
groups -- one that stopped receiving probiotic several weeks before the end of the trial, 
and one that received the higher dose of probiotic near the end of our trial. Two sets of 
these three types of wings were used. 
One set of 3 wings were inoculated with 5x105 conidia/mL water suspension on 
two equal portions of the wing. One portion was scratched with an inoculation loop to 
promote germination and this was compared to unscratched areas of the wings. Pd 
hyphae are known to penetrate bat wing tissue (Meteyer et al. 2009) and scratching 
could assist Pd growth. The other set of three wings were grown in the same conditions; 
however, they were placed directly onto SDA agar instead of cork board. Wings were left 
for one month and examined daily for fungal growth. Observed fungal growth was 
swabbed with sterile polyester tips and transferred onto SDA plates. It should be noted 
that the probiotic cocktail present on these captive bats were a pilot blend of two 
synergistic bacterial strains of Pseudomonas. 
In Experiment B, I Pd-challenged wings of another set of captive bats 
(euthanized in July 2019; control vs treatment; refer to Chapter 2 for details) that had 
been inoculated with the final probiotic cocktail blend of four bacteria (see Probiotic 
Cocktail section above). There were 6 treatment bat wings (n = 6 bats) that were 
previously exposed to the probiotic that inhibits WNS, and 5 control wings (n = 5 bats) 
that had not been exposed to the probiotic bacteria. The bat wings were used 
immediately after necropsy to reduce wing decay as a confounding factor. The other 
wing that was not used, was for the histological examination (see chapter 2).  
Two different methods of Pd application were used. The first method used a 
polyester swab that was rubbed onto a mature Pd plate that was established onto 
Sabouraud Dextrose Agar (SDA) and had uniform mycelia growth. A swab was pushed 




swab was then rubbed onto a wing. An individual swab was rubbed onto two treatment 
group bat wings and two control bat wings, for a total of four swabs. With this method, 
there was an unknown amount of Pd added, but hyphae would be added not just spores 
to ensure sufficient inoculation of Pd to the wings. 
The second method used a different approach to applying Pd, which required 
application of spores only, not mycelia. Seven different doses of 150,000 spores were 
added together in Phosphate Buffer Solution (PBS) and vortexed in two intervals at 
5000rpm for 10 minutes. Each pellet was diluted with 1ml of yeast extract broth for 5 
hours on a 200rpm shaker at 14oC to assist with germination. Spores were vortexed at 
7500 rpm for ten minutes after the 5 hours and resuspended with sterile water, twice. 
Before the spores were applied to the wings, they were vortexed at 7500 rpm for ten 
minutes and the sterile water was decanted. A sterile swab was pushed into the 
centrifuge tube and rubbed against the pellet in the tube before being rubbed onto the 
wings. There were four doses for treatment bat wings and 3 doses were for control bat 
wings.  
Wings were placed into petri dishes and stretched into place with water agar 
anchor points. The water agar prevented the wing from closing and raised humidity 
within the plate. Petri dishes containing the wings were sealed profusely with a 
generous amount of parafilm and placed into a 14oC cooler for one month. After one 
month the wings were removed and placed into 50ml centrifuge tubes containing PBS 
solution. The wings were gently vortexed at medium-high for 30 seconds before being 
sent to McMaster University for qPCR analysis.  
In Experiment C, three bats (n=6 wings) from the captive hibernation trial were 
euthanized and immediately the skin tissue was exposed to Pd. These bats had shown 
substantial growth of probiotic bacteria on their wings during a 35 day hibernation period 
(see Chapter 2 Results).  A new in-house method was used to grow Pd without 
interference from competing mold or fungi. Methodology was changed because of other 




growth rate of Pd. We developed a new method that attempted to prevent fast growing 
fungi from outcompeting Pd. 
Five SDA plates growing a uniform Pd mycelium were scraped and blended in 
saline solution for 30 seconds. The suspension was then centrifuged into concentrated 
micro doses of 0.2 mL PBS solution containing Pd mycelia – defined as a ‘dose’ for this 
experiment. A single ’dose‘ was inoculated onto each treatment wing (n = 6) and a 
previously frozen severed wing (n = 1) from an untreated bat of the same species. For 
comparison, as a ‘standard positive’ for Pd, one ‘dose’ was immediately frozen and sent 
as a comparison to treated wings. Treated wings were placed into a 14oC incubator for 
1 week before being placed into PBS solutions and frozen to stop Pd growth. Wings 
were analyzed by qPCR for growth over the time period.  
To analyze Pd growth/quantities in control versus treatment wings post 
incubation, in all experiments, we visually inspected the wings and fungus for similarities 
to Pd using a dissecting microscope before sending for qPCR analysis. Fungi was re-
isolated onto SDA and examined for growth rate and morphology. Examination of 
isolates was compared to Pd cultures previously grown on SDA plates.  
Pd Challenge - Ex vivo explants 
The purpose of the explant experiment was to test the Pd inhibition threshold of 
the anti-Pd bacteria -- Pseudomonas synxantha, strains A and B; P. azotoformans; and 
P. antarctica -- on live bat tissue. Severed tissue explants can be kept partially alive 
within specialized chambers in an ex vivo experiment, thus preventing the associated 
interference of decomposition (Figure 4.1). Wild captured M. yumanensis bats (n=3) 
were euthanized by overdosing via isoflurane at Thompson Rivers University in 
Kamloops, BC. Each bat’s patagium was separated into 1 cm diameter samples using a 
biopsy punch to collect full-thickness samples of skin (n=24). Biopsy punches were 
placed into the individual explant chambers quick enough to ensure constant source of 
nutrients to maintain cellular activity in skin cells. One side of the explant was exposed 
to Eagle’s modified minimal essential medium supplemented with or without antibiotics 




Explants were separated into two groups, 3 days and 7 days, and two 
subgroups, with and without gentamycin (Table 4.1). Two lengths of time were used 
because, due to this being a novel experiment, we were unsure how long the Pd would 
take to grow and/or colonize the skin tissue within the explant chambers. Ultimately, the 
time periods ended up being 3.5 and 7.5 days to test different timeframes. Seven and a 
half days was chosen to give the Pd enough time to grow but hopefully not be 
outcompeted by other fungi. Three and a half days was chosen to see if Pd numbers 
grew in quantity and to avoid any competing fungi possibly growing on the explant if left 
longer.  
Samples that were exposed to antibiotic media (n = 13) were compared to 
samples that did not have any exposure to antibiotic media using qPCR (n=11). Post-
experiment, a subsample of the explants (n=5) were examined using Scanning Electron 
Microscope (SEM) analysis to visualize Pd colonization and microscopic interactions 
between the probiotic bacteria, Pd and gentamycin, at the end of the 3 and 7 day trials. 
SEM samples were also swabbed for qPCR and were used in both the qPCR and SEM 
groups.  
 
Figure 4.1. Explant chambers that contain separated myotis patagium A) Myotis 
patagium with antibiotic, Pd and probiotic; and B) Myotis patagium with only Pd and no 





Table 4.1. Number of samples in each category that were exposed to media with 
antibiotics, media without antibiotics, and sent for SEM analysis. Group 1 consists of 
samples that had endpoints of 3.5 days, and group are samples with an endpoint of 7.5 
days. 










Add Probiotic (3.5 
days) 
3 2 0 0 
No Probiotic (3.5 
days) 
2 2 0 0 
Probiotic + Pd 
(3.5 days) 
2 2 0 0 
Pd only (3.5 
days) 
0 0 1 0 
Add Probiotic (7.5 
days) 
2 1 0 1 
No Probiotic (7.5 
days) 
2 1 0 1 
Probiotic + Pd 
(7.5 days) 
2 2 0 1 
Pd only (7.5 
days) 
0 1 1 0 
 
Probiotic bacteria were grown in individual flasks of LB broth in a 25oC incubator 
4 hours before bat euthanasia. Cell concentrations in each probiotic dosage were as 
follows:  500 cells of P. synxantha strain B, 8500 cells of P. synxantha strain A, 200 
cells of P. azotoformans, and 200 cells of P. antarctica. Cell concentrations were 
estimated using Colony Forming Units (CFU) vs Optical Density (600nm) curves (Figure 
4.2). Six hundred nanometer wavelength was used due to the yellow/golden tint of LB 
broth that cells were grown in. Each inoculated broth was portioned based on CFU 
curve estimations and centrifuged at 4000 rpm for 5 minutes in a tabletop centrifuge. 
This process was repeated three times and rinsed with Phosphate Buffer Solution 
(PBS) to remove any broth from the final dosage. The final probiotic dosage contained 
all four bacteria species in 20µl of PBS which was pipetted onto the opposite surface of 




Pd spores were separated into individual dosages from a larger stock 
concentration and centrifuged at 10,000 rpm for 5 minutes. The Pd spores stock 
concentration was constituted of PBS with 0.02% Tween 20 to achieve even distribution 
of spores within inoculum once pipetted onto the explant. Eighteen hundred Pd spores 
were inoculated onto explants to monitor interactions with probiotic bacteria and 
antibiotics.  
 Explant chambers were sealed with parafilm and placed into a 14oC incubator. 
After 0.5 days, half of the surface area of each explant (except the Pd control) were 
swabbed with a sterile polyester-tipped swab before being placed into the incubator.  
This swab was placed into sterile water and frozen until qPCR analysis. The other side 
of the explants were swabbed at the end of the experimental periods (3.5 and 7.5 days, 
for Groups 1 and 2, respectively) to quantify probiotic and Pd spore quantity. Swabs 
were placed into sterile water and frozen until qPCR analysis.  
Five explants were sent for SEM analysis: two with Pd spores inoculum only with 
no exposure to antibiotic media over 3.5 and 7.5 days, respectively; one with probiotic 
inoculum only and exposed to antibiotic media over 7.5 days; one with no inoculum and 
was exposed to antibiotic media for 7.5 days; and one with probiotic and Pd inoculum 
and was exposed to antibiotic media for 7.5 days. The quantitative PCR was conducted 
using the previous methodology in this thesis (See chapter 2 and 3 methods). 






Figure 4.2. Plotted CFU versus OD at 600nm of Pseudomonas synxantha, Strains A 





Ex vivo Wing Cultures 
Neither treatment nor control group wings exhibited any significant Pd growth 
in experiments A, B and C. This was determined through all methods of evaluation:  
visual examination, examination under a microscope, and through qPCR analysis of 
mycelia DNA quantity.  Other species of fungi grew on the wings that were different 
visually and morphologically different from Pd. Fungi isolates exhibited rapid, 
irregular growth once they were plated onto SDA agar and visualized for growth rate 
and morphology. I concluded that bat wings plated onto SDA agar exhibited an 
increased number of bacteria and fungi growth that were not associated with our 
experiment. As this was first noted in Experiment A, a revised protocol was used in 
Experiment B, as described in Methods, to minimize the likelihood of other microbes 
dominating the bat tissue, however, this too was unsuccessful – Pd growth on both 
groups of wings was minimal and other forms of unidentified fungi and mold were 
present (Figure 4.3).   
 
Figure 4.3. Separated bat wing from a control bat one week after Pd inoculation 
using the first application method, in which Pd was swabbed onto the bat tissue. 




The germination of Pd spores was minimal despite having grown Pd spores in 
yeast broth before inoculation. One bat in Experiment B exhibited increased number 
of Pd mycelia (L Metal R Grey individual; Figure 4.4), however, this was the only 
sample.  In Experiment C (Figure 4.5), qPCR results suggests that Pd either 
degraded on the wing tissue or, more likely, sampling and qPCR procedures 
interfered with the analysis. The frozen ‘dose’ was approximately the same number 
of Pd that was placed onto each wing in the frozen, control and treatment groups. 
Therefore, measuring the number of Pd in the mycelial sample in PBS may have 
worked much better in comparison to sending the entire wing submerged in PBS in 
for analysis. This major difference in quantity between the mycelial sample and wing 
samples is likely attributed to the sampling procedure. 
 
 
Figure 4.4. Number of Pd mycelia detected on control and treatment wings from the 
summer trial. The x axis is each individually identified captive bat. There were two 
bats designated as “nobands”, one in the control group and one in the treatment 












Figure 4.5. Average Pd mycelia concentrations on the treated bat wings and 
controls. A wing from a previously frozen bat of the same species was used as a 
control and dosed with the same concentration as the treated wings (frozen). The 
sample ‘mycelia’ is not a wing sample, but the Pd stock solution (standard) used for 
comparison. Suspensions were concentrated 10x in an attempt to quantify lower 









Ex vivo Explant Results 
Pd Quantities 
Quantitative PCR Cq results were compared between the 3.5 and 7.5 day groups 
and the subgroups that did or did not use antibiotics when inoculated with either Pd 
alone, probiotic alone, Pd and probiotic, or nothing (Table 4.2). All samples exposed to 
antibiotic medium had inconsistent results and/or showed little to no Pd or probiotic in 
the qPCR analysis. This suggests that gentamycin antibiotic destroyed Pd spores and 
probiotic cells on the explants, ultimately resulting in DNA degradation of these cells 
and inconclusive qPCR results. Inoculated samples in both Groups 1 and 2 provided 
evidence of Pd spores upon first swabbing. However, at the termination of each 
experiment, 3.5 and 7.5 days later, respectively, qPCR of swab samples revealed no Pd 
was evident (Tables 4.2). 
Swabs of wing tissues with probiotic that were not exposed to antibiotic were 
more consistent. Pd concentrations in Group 1 (3.5 days) decreased when exposed to 
bacteria inoculation on the same surface. The Pd Cq numbers changed from 37.75 to 
38.44, and from 38.16 to 38.19, signifying decreases in the amount of Pd DNA present 
on these two explants (Table 4.2). One of the explants in Group 2 (7.5 days) produced 
similar Pd reduction (Cq from 36.5 to 37.0; Table 4.2). The other explant changed in Cq 
values from 36.72 to 39.54, signifying a massive increase in Pd concentration. The 
inconsistencies observed may be largely due to swab sampling error, confounded by 
small sample sizes. Some contamination of Pd was evident among some of the 
explants and could largely be due to the explants sharing the same incubator. 
The Pd control was not exposed to antibiotic and was swabbed after 3.5 days 
and 7.5 days, demonstrating a higher detection count (lower Cq) after 7.5 days than at 
3.5 days (Table 4.2). Notably, although only a single sample, the Cq concentration of Pd 





Table 4.2. Baseline and endpoint swab sample Cq results of Pd from the Group 1 and 2 
explants. Inconsistent or unexpected results are highlighted in yellow. 
With antibiotic Without antibiotic 
Group 1 
Cq after 0.5 
days 
Cq after 3.5 
days   
Cq after 0.5 
days 
Cq after 3.5 
days 
With probiotic (A) 30.44 0 With probiotic (A)  0  0 
With probiotic (B)  0 0 With probiotic (B)  0  0 
With probiotic (C)  0 0      
      
   
With no probiotic (A)  0 35.7 With no probiotic (A)  0 37.74 
With no probiotic (B)  0 0 With no probiotic (B)  0  0 
      
   
Probiotic + Pd (A) 38.5   Probiotic + Pd (A) 37.75 38.44 
Probiotic + Pd (B) 39.49   Probiotic + Pd (B) 38.16 38.19 
    Pd Only  37.36 
Group 2 
Cq after 0.5 
days 
Cq after 7.5 
days   
Cq after 0.5 
days 
Cq after 7.5 
days 
With probiotic (A)  0 0 With probiotic (A)  0 39.02 
With probiotic (B)  0 0      
      
   
      
   
With no probiotic (A)  0 0 With no probiotic (A)  0  0 
With no probiotic (B) 32.79 0      
      
   
      
   
Probiotic + Pd (A) 0  0  Probiotic + Pd (A) 36.5 36.99 
Probiotic + Pd (B) 40.4 0  Probiotic + Pd (B) 39.54 36.72 
      Pd Only   37.26 
 
Probiotic Quantities 
Each of the three probiotic bacteria, P. azotoformans, P. synxantha strain A, and 
P. synxantha strain B were analyzed for each of the two experimental groups:  0.5 day 
baseline, 3.5 day endpoint, and 7.5 day endpoint, with and without antibiotics. Results 
for the fourth bacteria, P. antarctica, are largely inconsistent due to difficulties with 
custom gyrB probe for this species not annealing and thus resulting in poor DNA 
amplification. A change in  probiotic Cq values could be calculated for 8 explants only 
due to failure of some samples to amplify DNA.  Six of these 8 samples showed an 




experiment (ie. Cq values increased; Tables 4.3 and 4.4). Two explants, one with (3.5 
day group) and one without (7.5 day group) Pd inoculation, showed an overall increase 
in probiotic cells during the course of the experiment.  
In conclusion, I saw many inconsistencies in the explants, most notably those 
exposed to the gentamycin antibiotic, similar to the results of the Pd qPCR results 
above (Tables 4.3 and Table 4.4). However, other inconsistencies point towards 
additional methodological concerns such as small sample sizes, sources of cross-
contamination of Pd spores, sampling biases (possibly due to adherence of cells on 

















Table 4.3. qPCR results of P. azotoformans, P. synxantha strain A, P. synxantha strain 
B, and P. antarctica from the 3.5 day group 1. Inconsistent or unexpected results are 
highlighted in yellow.  
Group 1 Cq values from qPCR 
  
Starting Point (qPCR 0.5 days)  
with antibiotic 
Endpoint (qPCR 3.5 days) 






















(A) 0 0 0 0 0 0 0 0 
With 
probiotic 
(B) 33.61 35.81 33.81 37.37 38.96 38.98 38.34 0 
With 
probiotic 
(C) 38.09 39.64 38.97 40.58* 40.08 42.34 40.01 0 
                 
With no 
probiotic 
(A) 44.95 0 38.37 0 0 0 0 0 
With no 
probiotic 
(B) 0 0 0 0 0 0 0 0 
                 
Probiotic + 
Pd (A) 0 0 0 38.62 25.27 27.71 25.53 27.5 
Probiotic + 
Pd (B) 37.2 38.79 37.93 39.82 35.29 37.27 35.5 36.55 
  
Starting Point (qPCR 0.5 days)  
 
without antibiotic 





(A) 38.78 39.88 39.07 0 0 0 0 0 
With 
probiotic 
(B) 35.21 36.98 35.46 39.56 38.86 39.01 38.99 38.26 
                
With no 
probiotic 
(A) 0 0 0 0 0 0 0 0 
With no 
probiotic 
(B) 0 0 0 0 43.94 0 40.28 0 
                
Probiotic + 
Pd (A) 36.83 38.5 37.15 0 0 0 0 0 
Probiotic + 







Table 4.4. qPCR results of P. azotoformans, P. synxantha strain A, P. synxantha strain 
B, and P. antarctica from the 7.5 day group 2. Inconsistent or unexpected results are 
highlighted in yellow.  
Group 2 Cq values from qPCR 
  
Starting Point (qPCR 0.5 days)  
 
with antibiotic 























probiotic  42.11 43.9 42.64 0 0 0 0 0 
 37.95 39.55 38.72 0 41.49 0 42.04 42.12 
                  
With no 
probiotic 
(A) 0 0 0 0 40.92 42.24 42.02 38.73 
With no 
probiotic 
(C) 0 0 0 0 41.29 42.79 42.1 0 
                  
Probiotic + 
Pd (A) 0 0 0 0 36.24 38.53 36.88 0 
Probiotic + 
Pd (B) 37.74 39.36 38.24 37.88 0 0 0 0 
  
Starting Point (qPCR 0.5 days)  
 
without antibiotic 





(A) 38.97 40.82 38.82 42.05 23.71 25.75 24.11 31.66 
                 
With no 
probiotic 
(A) 0 0 0 0 0 0 0 0 
                 
Probiotic + 
Pd (A) 37.2 38.53 37.77 45.04 37.93 39.32 38.52 0 
Probiotic + 












Here we tested methods of inoculating Pd onto both dead and live bat tissue in 
multiple experiments, as well as testing interactions between the anti-Pd probiotic 
bacteria and Pd. We found that there were inherent difficulties with utilizing dead tissue 
as a replicate for Pd infection and other variables may have impeded the results. Using 
live wing tissue explants allowed us to hurdle some of the dead tissue complications 
and Pd was more easily detectable by qPCR and did not have other competing molds to 
interact with. However, low cycle numbers were evident and likely due to inadequate 
sampling procedures. Each experiment provided insight into what Pd inoculation studies 
should consider before an experiment begins. 
Wings that were inoculated ex vivo produced few spores or mycelial growth when 
analyzed by qPCR. Pd was difficult to visualize based on the fast growth of competing 
decay molds. Natural microbes on the wing grew faster on the decaying tissue and out 
competed Pd even while growing in optimum Pd  growth conditions of 14oC and high 
humidity. A growing fungi was easily distinguishable as not being Pd when it was 
isolated into subculture, based on its morphology and fast growth within 1-2 days 
compared to Pd which naturally takes at least 3-5 days to see any growth on SDA. 
Spores were grown in yeast extract to promote mycelia growth before inoculation still 
could not out compete decaying molds on the bat wings. Utilizing blended Pd mycelia 
was successful on frozen bat wings and SDA agar in previous trials (Not shown here), 
however it was unsuccessful on the final set of bat wings from the hibernation trial. 
There was some slow growing white fungal growth seen on the bat wings before 
submerging it into PBS for analysis. Pd mycelia were detected in the PBS solution 
control in the correct concentration however it was not detectable on the severed bat 
wings when the submerged PBS was tested for Pd. This is likely due to interference 
from skin tissue preventing qPCR probes from detecting Pd, or difficulties with sampling 
and extracting the spores from the large suspension in which the wing was submerged 
in. Future efforts would need to consider utilizing a swab or smaller wing sample for 




colonization of wing tissues. Furthermore, although Pd mycelia can grow quickly on 
frozen wings, this dosage does not reflect natural Pd infection in wild bats regarding 
concentration and mechanism (Makanya et al 2007; Meteyer et al. 2009). Finally, dead 
wing tissue is considerably different than live tissue in terms of growth conditions. 
Sebum and skin composition, which are crucial factors for skin microbes, are 
particularly different in dead tissue than live tissue and do not replicate typical growth 
medium for Pd (Wei et al. 2020).   
Non-antibiotic results from the explant experiment suggest that there was some 
interaction between Pd spores and anti-Pd bacteria. Both “Probiotic+Pd” explant 
samples from group 1 that were not exposed to antibiotic decreased in Pd concentration 
in relation to the Pd control, which instead increased. This could signify that probiotic 
bacteria were antagonistic towards Pd growth. Pd concentration in one sample 
increased in group 2 by nearly 3 fold (“Probiotic+Pd (B), without antibiotics”), however 
bacteria concentration was quite low in comparison to other explants after 7 days. We 
failed to detect any probiotic after 3.5 days on samples “With probiotic (A)” and 
“Probiotic+Pd (A). P. antarctica was largely the most inconsistent result of all the 
probiotic bacteria and was not detected when other bacteria were. This can be seen in 
nearly all samples of probiotic+Pd in group 2. Low Cq numbers are likely stemmed from 
swab sampling and inadequate pick-up of spores and/or probiotic cells. Due to the 
design of the explant chamber and low number of cells and spores involved, swabbing 
was likely an inferior method of extraction compared to utilizing the entire explant 
submerged in PBS for qPCR.    
Antagonism is still highly suggestive from every other sample exposed to 
probiotic bacteria decreased in Pd concentration. It is difficult to draw conclusions from 
qPCR bacteria results, however nearly all samples decreased in probiotic concentration 
when compared to their baselines. One sample from group 2 increased nearly 14 fold 
(“Probiotic (A)”), however this is likely due to sampling or inoculation error. Some 
samples had probiotic and Pd contamination which may have led to further ambiguous 




A similar experiment by Cornelison et al. in 2014b saw inhibition of Pd growth on 
explants that shared the same airspace as anti-Pd bacteria. In our experiment, each 
explant chamber was sealed with parafilm and inoculated on the same surface instead 
of different surfaces. The anti-Pd bacteria in our study has been shown to inhibit Pd on 
cultured agar, presumably through naturally released antibiotic metabolites such as 2,4-
Diacetylphloroglucinol (Delany et al. 2000; Bangera and Thomashow 1999). Bacteria 
were inoculated onto the surface of the explant before their growth phase and 
exponential growth to encourage its anti-Pd properties. Furthermore, the only explant in 
which we saw any fungal growth was on the control 3.5 and 7.5 day explants, in which a 
slow growing white fungus was forming without any probiotic interaction. This is 
encouraging to state that the inoculated probiotics may have impeded Pd growth 
however without a larger sample size it is difficult to make any assumptions from our 
results.  
Our results also suggested that utilizing antibiotic’s to prevent unwanted bacteria 
infection and mold growth were not necessary from our observations. No mold or visible 
morphological change of the explants occurred and explants that were not exposed to 
antibiotics were indistinguishable from ones that did. Furthermore, many qPCR results 
were ambiguous from explants that were exposed to antibiotic media for both the 3.5 
and 7.5 day groups. Although we were very diligent in attempting to prevent antibiotic 
exposure to the inoculum surface and did not visibly see leakage, there is a possibility 
that gentamycin antibiotic perfused through the epithelial matrix and interacted with both 
the probiotic and/or Pd inoculum. Future experiments should consider avoiding 
antibiotics unless necessary to prevent this interfering variable.  
We did not test for skin viability once the experiment concluded for both groups 
of explants. Although skin had the same texture and no signs of decay were present, we 
did not conclude this with a cross section and/or histological examination. No decay 
mold and similar feel to a live bat patagium may hint at live skin tissue. Future 
experiments should also consider utilizing a larger sample size for more robust results. 




would recommend using a larger sample size to monitor Pd and probiotic interactions 
on the live explant tissue. 
In conclusion, there are many obstacles and variables to consider when 
inoculating Pd onto bat tissue for ex vivo experiments. Refining ex vivo experiments are 
important considerations when live bats are not available, or researchers do not want to 
replicate the rigorous methods of hibernating wild animals. Here we found that live 
tissue explants can be an encouraging possibility for future Pd inoculation experiments. 
Researchers need to consider the difficulty of using explant chambers and the 
forewarning of small sample sizes as seen here. Experiments should seriously consider 
not using antibiotics to prevent unwanted variables. We did not see any visual 
difference between explants that were or were not exposed to antibiotics, however 
qPCR results were mixed and ambiguous. The explant experiment was novel; however 
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Chapter 5. CONCLUSION 
This thesis covered three aspects of implementing an anti-Pd probiotic to fight 
WNS: Captive trial testing, field trial testing, and Pd challenge lab experiments.  
Following two separate captive trials, the probiotic has been shown to have no 
detrimental effects to bats, and can easily be transferred to bats indirectly using a 
mixture of clay powder and freeze-dried bacteria, a method of application that I 
developed. Probiotic bacteria were persistent on captive bats and bat boxes months 
after application, including when exposed to high summer heat in the 40-50oC range. 
Although viability of cells following these extreme temperatures has yet to be tested, P. 
synxantha A showed signs of proliferating in the bat boxes. Probiotic cells grew 
substantially, confirming viability when exposed to hibernation conditions.  
The field trial was on-the-ground evidence that probiotic can be successfully 
transferred from inoculated human-made structures onto wild bat wings. Wings of wild 
Myotis lucifugus and M. yumanensis bats roosting in bat box or building roosts at our 
study sites had detectable amounts of the probiotic species used in our probiotic 
cocktail, following inoculation of their roosting substrates.  
While the probiotic cocktail has performed well in vitro against Pd, it has yet to be 
properly tested to quantify its efficacy in vivo in the lab and in the field when bats 
hibernate in Pd infected sites. Through multiple experiments, I determined that Pd does 
not grow on dead bat tissue, presumably due to competition from fast growing molds. 
Explant experiments were an improvement because they utilized live tissue;  although 
challenging and requiring euthanizing of live bats, explant chambers present a 
promising tool for answering the question of in vivo efficacy of probiotic against Pd 
germination. However, low sample sizes of the pilot that I performed made it difficult to 
make conclusions. Refined methodology including using separate Bio-safety Cabinets 
(BSC) will help reduce cross-contamination; more euthanized bats will enable larger 
sample sizes; direct DNA extraction of tissue explants instead of swabs may reduce 
high variability; histology examination will enable viability testing; and inoculating 




In the field, realized reduction of WNS-caused mortality will not be possible until 
the bats in our study area are exposed to Pd in winter hibernation. Each spring Pd 
surveillance efforts are ongoing, and automated PIT tag readers track return rates of 
bats after hibernation allowing for these to be compared between Control and 
Treatment sites.  
There were many challenges associated with this project. It is near impossible to 
replicate a roost in a captive setting without an extensively large enclosure and minimal 
disturbance. Stress and capture myopathy are unpredictable variables that may prevent 
desired results due to unprecedented events such as weight loss, un-natural behaviour, 
and death (Jung et al. 2002). These factors were evident when conducting the captive 
trial experiments, in which some bats stopped eating and/or were not able to participate 
in the trial further. Most experiments had an acceptable sample size however the 
hibernation experiment, which is arguably one of the most important experiments in this 
thesis, falls short in sample size because of our bats falling victim to environmental 
conditions and stress from captivity. Further experiments should heavily consider these 
variables and start with a larger sample size to offset any unpredicted losses.  
In particular, the captive trial in 2019 (Chapter 2) had limitations such as number 
of assistants, space to construct enclosures, number of bats, having to develop an 
application method, problems with the P. antarctica primer, and using a novel study 
design. This led to smaller sample sizes over a shorter period than what we would have 
preferred. These problems resulted in an irregular study design that was not well suited 
to comparing treatment 1 to treatment 2 groups over different time periods, although 
comparing these two groups was not an objective. What would have been useful, in 
hindsight, was to have had a 3rd treatment group which could have received one dose of 
probiotic with exposure for a few weeks only, and then swapping of the bat boxes to see 
how long the bats retained probiotic on their wings. While this was done at the end of 
the captive trial, it was cut short after a few weeks to apply probiotic to the bats that 
would then enter into the hibernation experiment. If a second hibernation fridge and 




probiotic increased from small concentrations present, more closely simulating what 
might be the case if a bat in the wild receives probiotic application from its late summer 
roost, and then leaves to transition roosts for a few weeks or months prior to 
hibernation.  
The study design could have been improved by utilizing separate treatment 
enclosures in different locations with their own control enclosures also in different 
locations (to separate treatments into their own groups better), to ensure absolutely no 
cross-contamination. Treatments could have occurred at similar times and tested 
different concentrations or more frequent dosages. A larger sample size of bats would 
have been beneficial for more rigorous comparisons, but was limited by permitting. 
Similarly, testing the probiotic on additional species of bats was not possible due to 
permitting, but may have been interesting to compare results.  
Finally, we did not look at the metagenomics of the bat skin. In the future, 
researchers should strongly consider looking at the entire microflora of the inoculated 
bat species, to examine the shifts in their microbiome from introducing the probiotic 
species bacteria. While we attempted to do this, our samples contained small samples 
of DNA that were not easily analyzed. Some results from the metagenomic sampling 
may be forthcoming, but were not included in this thesis. 
Researchers have explored many routes to prevent WNS infection in hibernating 
bats. Chitosan, polyethelene glycol, P. fluorescens species complex bacteria, 
Rhodococcus rhodocrous, Trichoderma sp, terbinafine, vaccines, valencia orange oil, 
and propolis have all been considered for preventing Pd infection, as summarized in a 
paper by Hoyt et al. (2019). Similarities are evident between every manuscript because 
they overlap with objectives of developing an effective method of preventing Pd 
germination. This can otherwise be said in the general hypothesis, “If I apply X to this 
media (or bat) then Pd will not grow”. Two field trials using bacteria from the P. 
fluorescens species complex have already been successful (Cheng et al. 2016; Hoyt et 
al. 2019). The study by Hoyt et al. (2019) provides strong evidence that bats can be 




inoculated with anti-Pd bacteria from the P. fluorescens species complex emerged from 
hibernation later with a five fold increase in survivability. The study by Cheng et al. 
suggested that bats must be inoculated upon exposure to Pd but still provided evidence 
of certain bacteria within the P. fluorescens species complex lowering disease severity 
when Pd is present. Current knowledge and proposals of fighting Pd infection in wild 
bats are consistently changing however anti-Pd probiotics have been considered the 
most promising method, particularly in British Columbia where hibernacula are not 
known and preventative measures are needed instead (Fletcher et al. 2020; Weller et 
al. 2018). Probiotics are beneficial because anti-Pd bacteria can be isolated from bat 
wings and reintroduced into other local populations with little risk to or the bat’s health or 
natural microbiota (Thomas and Willis 1998). E. fuscus and some persisting populations 
of bats that survive WNS are known to have an abundance of anti-Pd microbiota that 
can prevent Pd infection during hibernation (Langwig et al. 2017; Lemieux-Labonté et 
al. 2020). I am hopeful that the anti-Pd bacterial cocktail described in this thesis can be 
applied as a prophylaxis to bats in BC to reduce overwinter WNS mortality rates bats 
from this province come in contact with Pd. 
Bats are an important contributor of downwards pressure on arthropods, 
specifically nocturnal flying insects such as mosquitos, moths, and beetles, and are 
considered one of the most important predators of nocturnal flying insects (Nagorsen 
1995). Adult little brown females eat thousand of insects a night (Anthony and Kunz 
1977; Kurta et al. 1989; Nagorsen 1995). Studies have shown that exclusion of bats 
dramatically increase the abundance of insects prevalent on plants (Kalka et al. 2008; 
Williams-Guillen et al. 2008), sometimes 2 fold. Boyles et al. (2011) estimated the value 
of insectivorous bats to be 3.7-53 billion USD a year in North America. Cost savings are 
due to decreased use of pesticides and applications needed to fight resistance in 
agricultural pests. This is worrying, because White-nose syndrome, among other 
conservation threats such as wind turbines, roads, habitat fragmentation and loss, and 
deforestation have incredibly devastated bat populations (Berthinussen et al. 2014). 
White-nose syndrome is responsible for over 6 million bat deaths and recently emerged 




many species is real and often the result of emerging infectious diseases (Daszak 2000; 
De Castro and Bolker 2004).  
The overarching conservation goal of this project was to prevent, or lessen, the 
number of deaths caused by WNS once it arrives in British Columbia. This project is 
unique in all of North America as there are no other studies of using probiotic as a 
prophylaxis applied at maternity roosts. Much of the methodology employed in this 
project, and use of bio-augmentation via probiotics is novel (Thomas and Willis 1998). 
This work has established a foundation for other researchers to replicate and build 
upon.  
Future research directions are limited in preventing and/or stopping WNS from 
causing mass mortalities in western hibernating bat species. Studies should consider 
two goals, 1. Build on the preventative measures that we suggest in this thesis, and 2. 
Urgently increase bat population monitoring and assess hibernacula for signs of WNS. 
Bats mostly hibernate in small clusters in the western North America (Weller et al. 2018) 
making it difficult to locate bat hibernacula. Here we propose a solution using bat boxes 
and man made structures to transfer anti-Pd probiotic onto roosting bats. However, this 
may limit the application potential of rural areas where bat boxes may be impossible to 
maintain or dose properly. Ideally, we would want to apply our probiotic to known areas 
of hibernacula and monitor for Pd and probiotic levels. Because of the short time frame, 
incredible difficulty and sparse groupings, it is likely impossible to directly apply the 
probiotic to bat hibernacula. Refining a preventative measure is the only plausible option 
currently available. Bat monitoring should continue with the thought of direct hibernacula 
inoculation, but not relied on. Future field trials would benefit from a repeated, and 
higher dosage of anti-Pd bacteria on bat boxes in October with minimal disturbance to 
the roosting colony. It would be beneficial to investigate treatment frequency and 
dosages needed to maintain a viable concentration of bacteria that release the anti-Pd 
metabolites needed to prevent WNS infection. Further, if a nutrient supplement that 
stimulated pseudomonas metabolite production was proven safe in another captive trial, 




There are many different research directions to take in preventing WNS in western bat 
species and time is running out. Researchers will likely have to compromise on the best 
possible approach with whichever prophylaxis they finalize on and where to apply it. 
WNS will inevitably be found in British Columbia and it is up to researchers to decide on 
what is the best possible approach to prevent mass bat mortality.  
Studies performed in this thesis were in collaboration with the BC Ministry of 
Agriculture, McMaster University, UBC Okanagan, and Wildlife Conservation Society 
Canada. Capture information came from Leah Rensel of UBCO, and the qPCR results 
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Figure A.1. Inhibition of Pd in pairwise combinations A) measuring full zone of clearing; 
B) partial zone of clearing; C) Fractional Inhibitory Concentration Index for full inhibition; 












APPENDIX B. Animal care 
Summer 2019 Trial 
Twenty M. yumanensis were used in our captive trial, and were taken from 
Creston, Kuskanook, Chase, and Lardeau areas in British Columbia. Bats were brought 
into captivity in two batches. The first batch of 15 bats were captured within two days 
apart and were progressively placed into small, medium and large cages. Each bat was 
banded with one or two coloured bands on their forearms to differentiate them from 
each other. They were taught the principle of self feeding (mealworms) and self-drinking 
out of dishes throughout the acclimation process. This was performed by having 
mealworms and a water dish present within the mesh chamber for several days. 
Similarly to our fall trial, bats were manually fed mealworms and water for the first few 
days, with close observation on subsequent nights to ensure they are each drinking and 
eating without human intervention (observing colored bands). Bats were released from 
the large mesh enclosure and placed into our control enclosure for further acclimation. 
They were monitored daily for weights until evidence of self feeding and watering were 
shown. The amount of food and water accepted by each bat was recorded daily. Food 
stations consist of half aluminum foil cupcake tins filled with mealworms held in place by 
wooden boards to prevent shifting if the bats climbed into the food dishes. A water 
station was a dish kept topped up with an upside down bottle of water, and each dish 
was filled with marbles and had sponges on top which were regularly changed; these 
measures were taken to ensure sufficient water and prevent accidental entrapment or 
submersion of bats. Additionally, a mesh overlay on one end allowed bats to easily land 
above the water dish and climb down to approach its surface or the soaked sponges. 
Once the bats learned how to feed and water on their own, hand feeding and watering 
were not required. Bats were separated into Control and Treatment 1 groups when they 
were comfortable living within captivity, sustained their weight, and independently drank 
water. Mealworms were fed the same rich Omega 3 fatty acid diet used in the fall 
captive trial. This diet is a better approximation of one consisting of wild caught insects. 
The second batch of 5 bats were introduced into the Treatment 2 group at a later date 




Bats were monitored daily within their enclosure and were visited on a consistent 
time schedule each day. Little time was spent within the enclosure and noise was kept 
to a minimum to prevent disturbance and stress to the bats. They were removed from 
their bat house once a week for a health inspection by a registered Veterinarian 
Technician at the Kamloops BC Wildlife Park. Bats were placed into cloth bags and 
individually weighed before looking for details such as behaviour, body condition, injury, 
dehydration, and the condition of the eyes.  
Hibernation Trial 
The bats were introduced to the beverage cooler and it was set at 12-13oC, 
mimicking outside temperatures. Humidity was immediately introduced at >90% with 
mealworms, water and a roost pouch readily available. Each subsequent day, the 
temperature was dropped by 1oC until it reached 7-9oC. Bats were taught the principle 
of self-feeding and self-drinking out of a water dish during this time. Bats were manually 
fed mealworms and water for the first few nights, and closely observed on each 
subsequent night to ensure they are eating and drinking without human intervention. 
Each bat’s weight was monitored for weight loss or gain to presume self feeding. Once 
the optimum temperature was reached and bats had a steady weight of >6.0g to survive 
hibernation, we removed the mealworms and the roost pouch to entice hibernation. Two 
weeks later the temperature was dropped by another 1oC to approximately 6-8oC to 
further entice the bats to hibernate. Bats were meticulously monitored throughout the 
acclimation process and were checked daily with a Bluetooth infrared camera placed 
inside the fridge. Past and current bat activity was examined with the camera and 
identified with a coloured forearm band previously attached onto their wing. A red light 
was also used to watch the bats through the glass door and the checks were always 
completed within a dark room to prevent further disturbance. Notes were taken daily 
such as, roosting position of each bat, individual behaviour of each bat, temperature 
and humidity levels, water and food levels, and level of water in terrarium humidifier. 






APPENDIX C. Swabbing Area and Sampling Dates 
Table C.1. Swabbing area of the left arm, right arm, and both arms combined of bats 
from the 2019 captive trial. Excluded width of body. 
Bat Code Left arm length 
Right arm 
length Left+right arm length combined 
LMRP 9.91 10.16 20.07 
LMRG 10.80 10.29 21.08 
LM 9.33 9.21 18.54 
LMRB  9.72 10.41 20.13 
LMRLB 9.46 9.72 19.18 
LG 9.21 9.33 18.54 
LMRG 9.72 9.84 19.56 
NB 9.97 9.78 19.75 
LB 10.73 10.60 21.34 
LMRB 9.65 9.59 19.24 
LR 9.53 9.65 19.18 
LBRP 9.97 10.10 20.07 
LB 9.46 9.33 18.80 
LBRLB 9.53 9.65 19.18 
LG 10.22 10.35 20.57 
LLB 9.53 9.59 19.11 
RP 10.16 10.48 20.64 
LDB 9.72 9.84 19.56 
Mean 9.81 9.88 19.70 









Table C.2. Swab schedule of treatment 1 and 2 bats. 
Treatment group Date Swab Location Length 
Baseline Bat Swabs April 28th Right wing 9.88 
Treatment 1 Entire Sampling period Both wings 19.70 
Treatment 2 June 15th Right wing 9.88 
Treatment 2 June 29th Left wing 9.81 
Treatment 2 July 27th Left wing 9.81 
Treatment 2 Aug 9th Right wing 9.88 
Treatment 2 Aug 14th Left wing 9.81 
Treatment 2 Aug 24th Left wing 9.81 
 
 
Figure C.1 Representation of bat swab areas for Treatment group 1 and 2. Note: scale 
of photo is not accurate.  
 
Table C.3. Swab schedule of bats in the hibernation trial. 




First and Second 
finger bone (2) Third finger bone (3) 
Fourth finger 
bone (4) 
L Silver 4.3815 5.334 5.08 2.921 
L Silver R Green 4.445 6.35 4.6355 4.191 
No Bands 4.0005 5.334 4.8895 4.445 
Mean 4.27482 5.67182 4.86664 3.85064 
SE 0.054645321 0.133333333 0.050689688 0.185592145 
 





Figure C.2 Representation of bat swab areas for the Hibernation group. Note: scale of 
























APPENDIX D. Hibernation Fridge Temperature and Relative Humidity. 
 
 
Figure D.1. Temperature and relative humidity percentage within the hibernation 















APPENDIX E. Swab Broth Suspension Results. 
 
  
Figure E.1. Concentration of probiotic cells detected on treated bats in the Treatment 1 
group using qPCR for each probiotic bacteria species. Swab suspension was grown in 
broth for 12 hours and incubated at 25oC. Concentrations are corrected by wing area to 




































Figure E.2. Concentration of probiotic cells detected on the bat box in the Treatment 1 
group using qPCR for each probiotic bacteria species. Swab suspension was grown in 
broth for 12 hours and incubated at 25oC. Note the logarithmic scale. 
 
  
Figure E.3. Concentration of probiotic cells detected on treated bats in the Treatment 2 
group using qPCR for each probiotic bacteria species. Swab suspension was grown in 
broth for 12 hours and incubated at 25oC. Concentrations are corrected by wing area to 

























































Figure E.4. Concentration of probiotic cells detected on the bat box in the Treatment 2 
group using qPCR for each probiotic bacteria species. Swab suspension was grown in 
broth for 12 hours and incubated at 25oC. Note the logarithmic scale. 
 
  
Figure E.5. Concentration of probiotic cells detected from bat swabs in the hibernation 
trial using qPCR for each probiotic bacteria species. Swab suspension was grown in 
broth for 12 hours and incubated at 25oC. Concentrations are corrected by wing area to 





























































Figure E.6. Concentration of probiotic cells detected within the four-chamber bat box 
using qPCR. Swab suspension was grown in broth for 12 hours and incubated at 25oC. 



































































































19-1004-F Black  
1st Treatment 
Period only 






4.6 7 4-Nov-18 Good 
A LOT of large 
foamy 
macrophages in 
the lungs in 
septa and 





19-1004-D Blue P 
1st & 2nd 
treatments 










1st & 2nd 
treatments 
5.2 6.2 4-Nov-18 Good 




*bat died of fall while torpid 
* This was attributed to bats preparing for 
hibernation (Bouma et al. 2010; see 
Chapter 2 Results). 











































Grey* Black  
Purple 
P 
Blue P Green 
 
WING 30 23 0 2 1 1 24 2 16 
 
TAIL 24 15 13 0 0 2 20 19 17 
 
EAR 0 0 0 0 0 0 1 0 0 
 
NOSE 33 12       0 0 0 0 
 
 








count 4 3       3 5 4 1 
 
 
                  
 
OVERALL 




    
31.75 
    
           
* 
these 3 bats died and were sent for necropsy; the others were all euthanized at the 
end of the trial period in early Nov. 
Note: 
Segs and Monos - these tests are on a scale of 0 - 100 but are shown here instead as 




bats that were Controls or died before treatments began; italics are bats that were not 
in captivity as long as the other bats (died prematurely) 
Light 
shade 
bats that received probiotic treatment; italics are bats that received a large dose of 
probiotic in last week or trial vs non-italics are Treatment bats that did not receive 




Table F.2. Histology scores of wing tissue from bats within the 2019 summer captive trial. These 
consisted of Control and Treatment 1 groups. 
Wing 
        








Good control 1 0 2 0 2 0 100 
Good control 2 1 2 2 1 0 100 
Good control 3 2 3 0 3 0 100 
Good control 1 0 2 1 1 0 100 
Good control 2 1 3 1 2 25 75 
Good control 1 0 3 0 3 0 100 
Good T1 2 1 3 1 3 25 75 
Good T1 3 1 3 0 3 0 100 
Good T1 2 0 1 0 1 0 100 
Good T1 2 0 3 0 3 25 75 
Good T1 1 0 1 0 1 0 100 
Good T1 2 2 2 0 2 25 75 
Good T1 2 1 3 3 3 50 50 
Control mean 
 




2 0.714 2.29 0.571 2.286 
  






Ulceration Hemorrhage Mites Yeast 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 




Table F.3. Histology scores of tail tissue from bats within the 2019 summer captive trial. These 
consisted of Control and Treatment 1 groups. 
Tail 
        
PM 
preservation 








Good control 0 0 2 0 3 25 75 
Good control 1 1 0 0 0 0 0 
Good control 2 0 4 1 3 25 75 
Good control 2 1 3 0 3 25 75 
Good control 1 0 1 0 1 25 75 
Good control 1 0 2 0 2 0 100 
Good T1 1 1 1 0 1 0 100 
Good T1 1 0 2 0 2 0 100 
Good T1 0 0 0 0 0 0 0 
Good T1 1 0 1 0 1 25 75 
Good T1 0 0 0 0 0 0 0 
Good T1 0 0 2 2 0 100 0 
Good T1 1 0 1 0 1 0 100 
Control 
mean  




0.571 0.143 1 0.286 0.714 
  






Ulceration Hemorrhage Mites Yeast 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 




Table F.4. Histology scores of ear tissue from bats within the 2019 summer captive trial. These 
consisted of Control and Treatment 1 groups.  
Ear 
      
PM 
preservation 







Good control 0 0 2 0 2 
Good control 0 0 2 0 2 
Good control 0 0 2 0 2 
Good control 0 0 0 0 0 
Good control 0 0 0 0 0 
Good control 0 0 0 0 0 
Good T1 0 0 4 0 4 
Good T1 0 0 1 0 1 
Good T1 0 0 2 0 2 
Good T1 0 0 3 0 3 
Good T1 0 0 0 0 0 
Good T1 0 0 0 0 0 
Good T1 0 0 1 0 1 
Control 
mean  
0 0 1 0 1 
Treatment 
mean  
0 0 1.571 0 1.571 






Ulceration Hemorrhage Mites Yeast 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 





Table F.5. Histology scores of nose tissue from bats within the 2019 summer captive trial. 
These consisted of Control and Treatment 1 groups 
Nose 











Good control 0 0 0 0 0 
Good control 0 0 0 0 0 
Good control 5 5 5 75 25 
Good control 1 0 1 0 100 
Good control 0 0 0 0 0 
Good control 0 0 0 0 0 
Good T1 0 0 0 0 0 
Good T1 0 0 0 0 0 
Good T1 0 0 0 0 0 
Good T1 0 0 0 0 0 
Good T1 0 0 0 0 0 
Good T1 1 0 1 0 100 
Good T1 0 0 0 0 0 
Control 
mean  




0.143 0 0.143 
  






Ulceration Hemorrhage Mites 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 3 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0.5 0 0 0 0 





Table F.6. Histology scores of lungs and spleens from bats within the 2019 summer captive trial. 










control 2 3 1 
control 1 2 1 
control 2 1 1 
control 2 2 2 
control 2 3 2 
control 1 3 1 
T1 1 1 n/a 
T1 2 3 1 
T1 1 1 1 
T1 1 2 n/a 
T1 1 2 1 
T1 1 3 0 
T1 2 3 n/a 
Control 
mean 
1.67 2.33 1.33 
Treatment 


















APPENDIX G. Captive Trial Experimental Design and Justification 
The experimental design involves 3 groups of bats which belong to the 
Treatment 1 group, Treatment 2 group, and the Hibernation group. Each group was 
independent of one another because of how they differed in their experimental design. 
The Treatment 1 group was inoculated with two probiotic dosages which were on May 
12th and May 24th, followed by weekly swabbing (swab areas can be found in Appendix 
C) of their wings. Treatment 2 group was only inoculated with one dosage of probiotic 
bacteria on June 15th. The bat box in the Treatment 1 group was changed out upon 
inoculating another dosage, whereas the Treatment 2 group bats used the same bat 
box that was initially inoculated. Therefore we are comparing two groups of bats that 
were exposed to differing concentrations of probiotic, one dosage versus two dosages 
of probiotic bacteria. The Hibernation group was independent of the other treatment 
groups because it was placed into entirely different environmental conditions within a 
hibernacula chamber (Appendix D).  
All replicates from each species of bacteria and on each swab date formulate a 
mean abundance of cells in each category (Table G.1, G.2, G.3). The standard error is 
calculated among all replicates due to the mean of probiotic bacteria being derived from 
these individual replicates. Of which, the mean of means of each bacteria from each bat 
would derive the same result as the mean of all replicates they originated from. 
Table G.1. Number of swabbed bats in the Treatment 1 group and qPCR data replicates 
of each bacteria species found across all bats. 




P. synxantha strain B 
replicates 
P. synxantha 
strain A replicates 
P. azotoformans 
replicates 
2019-05-26 7 14 15 15 
2019-06-01 7 9 8 7 
2019-06-08 7 2 2 2 





Table G.2. Number of swabbed bats in the Treatment 2 group and qPCR data replicates 
of each bacteria species found across all bats. 
















2019-06-29 3 4 4 4 0 
2019-07-13 3 1 1 1 0 
2019-08-09 3 1 1 1 2 
2019-08-14 3 2 2 2 0 
 
Table G.3. Number of swabbed bats in the Hibernation group and qPCR data replicates 















2019-11-16 3 9 9 9 6 
2019-11-28 3 9 9 9 9 
2019-12-08 3 9 9 9 9 
2019-12-18 3 3 3 3 0 

















APPENDIX H. Swab Protocol 
Step-by-step protocol 
INTRODUCTION: 
The objective of this sampling is to collect metagenomics data on the bat species 
and populations for conservation efforts. Metagenomic sampling of bats will provide 
total genomic data of a bat’s wing microbiome. 
 
Materials needed for each bat / environmental sample: 
 
Included in kit: 
1 vial of sterile NaCl (0.15M) buffer solution (for moistening swab and storing 
swab after sampling) 
1 ziploc bag (to place vial in when sampling is completed) 
1 sticker OR 1 piece of rite on rain paper (label with sample information) 
1 sterile swab with a predefined breakpoint on the stick 
 
Included in kit: 
One large Ziploc bag is included for each sampling session 
 
Also needed per sample: 
1 small Ziploc bag for individual samples 
1 pair of latex/nitrile gloves 
1 permanent marker 
Decontamination chemical (for WNS spread prevention) for any surface that 





i. Put on latex/nitrile gloves. 
ii. Fill in information on sticker/rite on rain paper. Include the following 7 information 
fields: 
NAME of Principal Investigator: 
DATE (MMM DD/YY) 
SITE  
BATID# 







If stickers are provided in your kit, this information should be filled out on the label with 
permanent marker and adhered to the inside of the small Ziploc bag. But if there is 
only rite on the rain paper, please write this information on the paper and place it 
inside the Ziploc bag. 
 
iii. Open the Whatman Omni swab package so that the swab handle is presented to the 
handler. Keep the tip of the swab inside the package to keep it sterile. Avoid contact 
with the tip of the swab. 
iv. Soak the tip of the swab in 0.15M NaCl buffer tube. Remove excess liquid from 
the swab by pressing the swab tip against the inside of the tube wall.  
v. Part 1 (to be completed for all bats). Swab the bat: 
a) Please read the precautions at the bottom of this protocol. 
b) Carefully swab the inside of the right wing (forearm and wing) in linear 
strokes. Cover the entire wing surface, slowly rolling or lightly brushing the 
swab over the skin.  This should take at least 12 seconds.  
c) Immediately place the swab into the vial -- Release the tip of the swab into 
the collection tube by pressing on the swab handle.  
d) Place collection tube into small Ziploc bag. Be sure there is a label on the 
inside of this bag (either a sticker or piece of paper). 
 
vi. Part 2 (To be completed only once at each capture site (Environmental Reference 
Swab -- to be completed only if there are known bat roosts at the sampling area). 
a) Using another Whatman omni swab, vial and fresh gloves, create a label with the 
following information fields: 
  NAME of Principal Investigator: 
 DATE (MMM DD/YY) 
SITE: 
ENVIRONMENTAL SUBSTRATE SWABBED: (e.g., inside rock crevice, 
mine wall, rafter of attic) 




b) Swab the wall/surface closest to where the bats are roosting or would typically 
roost for 10 seconds in a circle of approximately 5cm.  
• For example, if bats are captured outside of a rocky bluff area, and bats 
are thought to be using the rock crevices in the area, swab the inside of a 
randomly selected crevice. If an actual crevice roost is known, sample this 
instead. 
c) Release the tip of the swab into the collection tube by pressing on the swab 
handle. 





















APPENDIX I. Explant Protocol 
Myotis Explant SOP 
Introduction: 
The purpose of this SOP is to test the Pd inhibition threshold of the anti-Pd bacteria 
Pseudomonas synxantha, Strains A and B; P. azotoformans; and P. antarctica on live 
bat tissue. Severed tissue explants can be kept partially alive within specialized 
chambers, thus preventing the associated interference of decomposition. 
Materials needed: 
Autoclave and/or sterilize the following: 
→ Isoflurane 
→ Cotton balls 
→ Small mason jars with lids 
→ Large sterile scissors 
→ Surgical scalpel 
→ Clean cutting board 
→ Biohazard waste bag 
→ Sterile forceps 
→ Biosafety cabinet (BSC) 
→ Fume hood 
→ Calipers 
→ Gloves 
→ P20 & P200 pipettes and tips 
→ Explant chamber 
→ Explant hole-punch 
→ Eagles minimal essential medium 
→ Gentamycin  
→ Probiotic dosage 
→ Gas mask 
→ Prepared probiotic bacteria  




→ Scanning Electron Microscope (SEM) 





1. Gather necessary material in both the fume hood and BSC. Make sure to wear a 
mask that protects against volatile gases (i.e. Isoflurane). Add media with and 
without gentamycin antibiotics into the explant chambers and seal off with tinfoil. 
Leave the chambers in the BSC until the explants are extracted from the bats.  
 
2. To prepare for euthanasia, soak a cotton ball with a generous amount of 
isoflurane and place it into the bottom of a mason jar. Be sure to have positive 
airflow in the fume hood to avoid leaking of the anesthetic.  
 
3. Take the bat and place it into the jar containing the cotton ball soaked in 
isoflurane. After 1-2 minutes, the bat should be knocked out and unconscious 
from the anesthetic. The bat should overdose quite quickly.  
 
4. After the bat is no longer moving and at least 5 minutes have passed, remove the 
bat from the jar and move it to the BSC. Quickly decapitate the bat using a sharp 
pair of scissors to confirm euthanasia. Do not stop halfway through.  
 
5. Turn off laminar airflow going into the BSC. The anesthetic is contained within 
the separate fume hood and a sterile environment is not needed for sampling the 
explants.   
 
6. Using the explant hole-punch, sample skin tissue from the myotis wing patagium 
one at a time. Work quickly and diligently because samples can dry up and 





7. Place the sampled tissue into the explant chamber and screw both pieces of the 
apparatus together to seal the explant into place. Place tinfoil over top of the 
explant chambers. Repeat steps 6-7 until sufficient explants have been sampled 
or the tissue is starting to dry out.  
 
8. Turn on the laminar air flow and prepare probiotic dosages for application.  
 
a. Bacteria will be grown before application in LB broth. Utilizing growth 
curves, OD readings, and dilution calculations, a proper dosage can be 
achieved for all explants. Remove designated amount of each of the 4 
probiotics and mix them together. Prepare the same number of dosages 
as explants. 
 
b. Centrifuge at 4000rpm for ten minutes. Remove supernatant and flush 
with 1ml of PBS. Vortex on medium high.  
 
c. Repeat step b and centrifuge once more to remove any LB broth from the 
bacteria.  Remove supernatant and add 250ul of PBS. Vortex on medium 
high to displace the bacteria pellet.  
 
9. Inoculate each of the explants with the probiotic. 
 
10.  Inoculate the designated number of explants with Pd spores from previously 
prepared spore isolations. Refer to the spore isolation SOP for more info.  
 
11. Fully seal the explant chambers and place the bat corpses into the -80 freezer. 





12. After 3-4 days, half of the explants will be removed and monitored through SEM 
for spore germination and hyphae growth. Control will be compared to probiotic 
treatments at different spore loads, with and without antibiotics.  
 
13. After 1 week, monitor the other half of the explants for spore growth and 
germination. Remove explants and place them into PBS solutions. Freeze the 
samples. Pd and probiotic numbers can then be monitored through qPCR 
analysis.  
 
 
 
 
 
 
 
 
